{
    "atc": [
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01D",
            "level3_description": "VASODILATORS USED IN CARDIAC DISEASES",
            "level4": "C01DX",
            "level4_description": "Other vasodilators used in cardiac diseases",
            "level5": "C01DX04",
            "who_name": "benziodarone"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01D",
            "level3_description": "VASODILATORS USED IN CARDIAC DISEASES",
            "level4": "C01DX",
            "level4_description": "Other vasodilators used in cardiac diseases",
            "level5": "C01DX05",
            "who_name": "carbocromen"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01D",
            "level3_description": "VASODILATORS USED IN CARDIAC DISEASES",
            "level4": "C01DX",
            "level4_description": "Other vasodilators used in cardiac diseases",
            "level5": "C01DX06",
            "who_name": "hexobendine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01D",
            "level3_description": "VASODILATORS USED IN CARDIAC DISEASES",
            "level4": "C01DX",
            "level4_description": "Other vasodilators used in cardiac diseases",
            "level5": "C01DX07",
            "who_name": "etafenone"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01D",
            "level3_description": "VASODILATORS USED IN CARDIAC DISEASES",
            "level4": "C01DX",
            "level4_description": "Other vasodilators used in cardiac diseases",
            "level5": "C01DX08",
            "who_name": "heptaminol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01D",
            "level3_description": "VASODILATORS USED IN CARDIAC DISEASES",
            "level4": "C01DX",
            "level4_description": "Other vasodilators used in cardiac diseases",
            "level5": "C01DX09",
            "who_name": "imolamine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01D",
            "level3_description": "VASODILATORS USED IN CARDIAC DISEASES",
            "level4": "C01DX",
            "level4_description": "Other vasodilators used in cardiac diseases",
            "level5": "C01DX10",
            "who_name": "dilazep"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01D",
            "level3_description": "VASODILATORS USED IN CARDIAC DISEASES",
            "level4": "C01DX",
            "level4_description": "Other vasodilators used in cardiac diseases",
            "level5": "C01DX11",
            "who_name": "trapidil"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01D",
            "level3_description": "VASODILATORS USED IN CARDIAC DISEASES",
            "level4": "C01DX",
            "level4_description": "Other vasodilators used in cardiac diseases",
            "level5": "C01DX12",
            "who_name": "molsidomine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01D",
            "level3_description": "VASODILATORS USED IN CARDIAC DISEASES",
            "level4": "C01DX",
            "level4_description": "Other vasodilators used in cardiac diseases",
            "level5": "C01DX13",
            "who_name": "efloxate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01D",
            "level3_description": "VASODILATORS USED IN CARDIAC DISEASES",
            "level4": "C01DX",
            "level4_description": "Other vasodilators used in cardiac diseases",
            "level5": "C01DX14",
            "who_name": "cinepazet"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01D",
            "level3_description": "VASODILATORS USED IN CARDIAC DISEASES",
            "level4": "C01DX",
            "level4_description": "Other vasodilators used in cardiac diseases",
            "level5": "C01DX15",
            "who_name": "cloridarol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01D",
            "level3_description": "VASODILATORS USED IN CARDIAC DISEASES",
            "level4": "C01DX",
            "level4_description": "Other vasodilators used in cardiac diseases",
            "level5": "C01DX16",
            "who_name": "nicorandil"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01D",
            "level3_description": "VASODILATORS USED IN CARDIAC DISEASES",
            "level4": "C01DX",
            "level4_description": "Other vasodilators used in cardiac diseases",
            "level5": "C01DX18",
            "who_name": "linsidomine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01D",
            "level3_description": "VASODILATORS USED IN CARDIAC DISEASES",
            "level4": "C01DX",
            "level4_description": "Other vasodilators used in cardiac diseases",
            "level5": "C01DX19",
            "who_name": "nesiritide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01D",
            "level3_description": "VASODILATORS USED IN CARDIAC DISEASES",
            "level4": "C01DX",
            "level4_description": "Other vasodilators used in cardiac diseases",
            "level5": "C01DX21",
            "who_name": "serelaxin"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01D",
            "level3_description": "VASODILATORS USED IN CARDIAC DISEASES",
            "level4": "C01DX",
            "level4_description": "Other vasodilators used in cardiac diseases",
            "level5": "C01DX22",
            "who_name": "vericiguat"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01D",
            "level3_description": "VASODILATORS USED IN CARDIAC DISEASES",
            "level4": "C01DX",
            "level4_description": "Other vasodilators used in cardiac diseases",
            "level5": "C01DX51",
            "who_name": "itramin tosilate, combinations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01D",
            "level3_description": "VASODILATORS USED IN CARDIAC DISEASES",
            "level4": "C01DX",
            "level4_description": "Other vasodilators used in cardiac diseases",
            "level5": "C01DX52",
            "who_name": "prenylamine, combinations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01D",
            "level3_description": "VASODILATORS USED IN CARDIAC DISEASES",
            "level4": "C01DX",
            "level4_description": "Other vasodilators used in cardiac diseases",
            "level5": "C01DX53",
            "who_name": "oxyfedrine, combinations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01D",
            "level3_description": "VASODILATORS USED IN CARDIAC DISEASES",
            "level4": "C01DX",
            "level4_description": "Other vasodilators used in cardiac diseases",
            "level5": "C01DX54",
            "who_name": "benziodarone, combinations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01E",
            "level3_description": "OTHER CARDIAC PREPARATIONS",
            "level4": "C01EA",
            "level4_description": "Prostaglandins",
            "level5": "C01EA01",
            "who_name": "alprostadil"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01E",
            "level3_description": "OTHER CARDIAC PREPARATIONS",
            "level4": "C01EB",
            "level4_description": "Other cardiac preparations",
            "level5": "C01EB02",
            "who_name": "camphora"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01E",
            "level3_description": "OTHER CARDIAC PREPARATIONS",
            "level4": "C01EB",
            "level4_description": "Other cardiac preparations",
            "level5": "C01EB03",
            "who_name": "indometacin"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01E",
            "level3_description": "OTHER CARDIAC PREPARATIONS",
            "level4": "C01EB",
            "level4_description": "Other cardiac preparations",
            "level5": "C01EB04",
            "who_name": "crataegus glycosides"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01E",
            "level3_description": "OTHER CARDIAC PREPARATIONS",
            "level4": "C01EB",
            "level4_description": "Other cardiac preparations",
            "level5": "C01EB05",
            "who_name": "creatinolfosfate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01E",
            "level3_description": "OTHER CARDIAC PREPARATIONS",
            "level4": "C01EB",
            "level4_description": "Other cardiac preparations",
            "level5": "C01EB06",
            "who_name": "fosfocreatine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01E",
            "level3_description": "OTHER CARDIAC PREPARATIONS",
            "level4": "C01EB",
            "level4_description": "Other cardiac preparations",
            "level5": "C01EB07",
            "who_name": "fructose 1,6-diphosphate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01E",
            "level3_description": "OTHER CARDIAC PREPARATIONS",
            "level4": "C01EB",
            "level4_description": "Other cardiac preparations",
            "level5": "C01EB09",
            "who_name": "ubidecarenone"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01E",
            "level3_description": "OTHER CARDIAC PREPARATIONS",
            "level4": "C01EB",
            "level4_description": "Other cardiac preparations",
            "level5": "C01EB10",
            "who_name": "adenosine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01E",
            "level3_description": "OTHER CARDIAC PREPARATIONS",
            "level4": "C01EB",
            "level4_description": "Other cardiac preparations",
            "level5": "C01EB11",
            "who_name": "tiracizine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01E",
            "level3_description": "OTHER CARDIAC PREPARATIONS",
            "level4": "C01EB",
            "level4_description": "Other cardiac preparations",
            "level5": "C01EB13",
            "who_name": "acadesine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01E",
            "level3_description": "OTHER CARDIAC PREPARATIONS",
            "level4": "C01EB",
            "level4_description": "Other cardiac preparations",
            "level5": "C01EB15",
            "who_name": "trimetazidine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01E",
            "level3_description": "OTHER CARDIAC PREPARATIONS",
            "level4": "C01EB",
            "level4_description": "Other cardiac preparations",
            "level5": "C01EB16",
            "who_name": "ibuprofen"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01E",
            "level3_description": "OTHER CARDIAC PREPARATIONS",
            "level4": "C01EB",
            "level4_description": "Other cardiac preparations",
            "level5": "C01EB17",
            "who_name": "ivabradine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01E",
            "level3_description": "OTHER CARDIAC PREPARATIONS",
            "level4": "C01EB",
            "level4_description": "Other cardiac preparations",
            "level5": "C01EB18",
            "who_name": "ranolazine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01E",
            "level3_description": "OTHER CARDIAC PREPARATIONS",
            "level4": "C01EB",
            "level4_description": "Other cardiac preparations",
            "level5": "C01EB21",
            "who_name": "regadenoson"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01E",
            "level3_description": "OTHER CARDIAC PREPARATIONS",
            "level4": "C01EB",
            "level4_description": "Other cardiac preparations",
            "level5": "C01EB22",
            "who_name": "meldonium"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C01",
            "level2_description": "CARDIAC THERAPY",
            "level3": "C01E",
            "level3_description": "OTHER CARDIAC PREPARATIONS",
            "level4": "C01EB",
            "level4_description": "Other cardiac preparations",
            "level5": "C01EB23",
            "who_name": "tiazotic acid"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02A",
            "level3_description": "ANTIADRENERGIC AGENTS, CENTRALLY ACTING",
            "level4": "C02AA",
            "level4_description": "Rauwolfia alkaloids",
            "level5": "C02AA01",
            "who_name": "rescinnamine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02A",
            "level3_description": "ANTIADRENERGIC AGENTS, CENTRALLY ACTING",
            "level4": "C02AA",
            "level4_description": "Rauwolfia alkaloids",
            "level5": "C02AA02",
            "who_name": "reserpine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02A",
            "level3_description": "ANTIADRENERGIC AGENTS, CENTRALLY ACTING",
            "level4": "C02AA",
            "level4_description": "Rauwolfia alkaloids",
            "level5": "C02AA03",
            "who_name": "combinations of rauwolfia alkaloids"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02A",
            "level3_description": "ANTIADRENERGIC AGENTS, CENTRALLY ACTING",
            "level4": "C02AA",
            "level4_description": "Rauwolfia alkaloids",
            "level5": "C02AA04",
            "who_name": "rauwolfia alkaloids, whole root"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02A",
            "level3_description": "ANTIADRENERGIC AGENTS, CENTRALLY ACTING",
            "level4": "C02AA",
            "level4_description": "Rauwolfia alkaloids",
            "level5": "C02AA05",
            "who_name": "deserpidine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02A",
            "level3_description": "ANTIADRENERGIC AGENTS, CENTRALLY ACTING",
            "level4": "C02AA",
            "level4_description": "Rauwolfia alkaloids",
            "level5": "C02AA06",
            "who_name": "methoserpidine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02A",
            "level3_description": "ANTIADRENERGIC AGENTS, CENTRALLY ACTING",
            "level4": "C02AA",
            "level4_description": "Rauwolfia alkaloids",
            "level5": "C02AA07",
            "who_name": "bietaserpine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02A",
            "level3_description": "ANTIADRENERGIC AGENTS, CENTRALLY ACTING",
            "level4": "C02AA",
            "level4_description": "Rauwolfia alkaloids",
            "level5": "C02AA52",
            "who_name": "reserpine, combinations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02A",
            "level3_description": "ANTIADRENERGIC AGENTS, CENTRALLY ACTING",
            "level4": "C02AA",
            "level4_description": "Rauwolfia alkaloids",
            "level5": "C02AA53",
            "who_name": "combinations of rauwolfia alkoloids, combinations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02A",
            "level3_description": "ANTIADRENERGIC AGENTS, CENTRALLY ACTING",
            "level4": "C02AA",
            "level4_description": "Rauwolfia alkaloids",
            "level5": "C02AA57",
            "who_name": "bietaserpine, combinations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02A",
            "level3_description": "ANTIADRENERGIC AGENTS, CENTRALLY ACTING",
            "level4": "C02AB",
            "level4_description": "Methyldopa",
            "level5": "C02AB01",
            "who_name": "methyldopa (levorotatory)"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02A",
            "level3_description": "ANTIADRENERGIC AGENTS, CENTRALLY ACTING",
            "level4": "C02AB",
            "level4_description": "Methyldopa",
            "level5": "C02AB02",
            "who_name": "methyldopa (racemic)"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02A",
            "level3_description": "ANTIADRENERGIC AGENTS, CENTRALLY ACTING",
            "level4": "C02AC",
            "level4_description": "Imidazoline receptor agonists",
            "level5": "C02AC01",
            "who_name": "clonidine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02A",
            "level3_description": "ANTIADRENERGIC AGENTS, CENTRALLY ACTING",
            "level4": "C02AC",
            "level4_description": "Imidazoline receptor agonists",
            "level5": "C02AC02",
            "who_name": "guanfacine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02A",
            "level3_description": "ANTIADRENERGIC AGENTS, CENTRALLY ACTING",
            "level4": "C02AC",
            "level4_description": "Imidazoline receptor agonists",
            "level5": "C02AC04",
            "who_name": "tolonidine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02A",
            "level3_description": "ANTIADRENERGIC AGENTS, CENTRALLY ACTING",
            "level4": "C02AC",
            "level4_description": "Imidazoline receptor agonists",
            "level5": "C02AC05",
            "who_name": "moxonidine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02A",
            "level3_description": "ANTIADRENERGIC AGENTS, CENTRALLY ACTING",
            "level4": "C02AC",
            "level4_description": "Imidazoline receptor agonists",
            "level5": "C02AC06",
            "who_name": "rilmenidine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02B",
            "level3_description": "ANTIADRENERGIC AGENTS, GANGLION-BLOCKING",
            "level4": "C02BA",
            "level4_description": "Sulfonium derivatives",
            "level5": "C02BA01",
            "who_name": "trimetaphan"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02B",
            "level3_description": "ANTIADRENERGIC AGENTS, GANGLION-BLOCKING",
            "level4": "C02BB",
            "level4_description": "Secondary and tertiary amines",
            "level5": "C02BB01",
            "who_name": "mecamylamine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02C",
            "level3_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
            "level4": "C02CA",
            "level4_description": "Alpha-adrenoreceptor antagonists",
            "level5": "C02CA01",
            "who_name": "prazosin"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02C",
            "level3_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
            "level4": "C02CA",
            "level4_description": "Alpha-adrenoreceptor antagonists",
            "level5": "C02CA02",
            "who_name": "indoramin"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02C",
            "level3_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
            "level4": "C02CA",
            "level4_description": "Alpha-adrenoreceptor antagonists",
            "level5": "C02CA03",
            "who_name": "trimazosin"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02C",
            "level3_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
            "level4": "C02CA",
            "level4_description": "Alpha-adrenoreceptor antagonists",
            "level5": "C02CA04",
            "who_name": "doxazosin"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02C",
            "level3_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
            "level4": "C02CA",
            "level4_description": "Alpha-adrenoreceptor antagonists",
            "level5": "C02CA06",
            "who_name": "urapidil"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02C",
            "level3_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
            "level4": "C02CC",
            "level4_description": "Guanidine derivatives",
            "level5": "C02CC01",
            "who_name": "betanidine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02C",
            "level3_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
            "level4": "C02CC",
            "level4_description": "Guanidine derivatives",
            "level5": "C02CC02",
            "who_name": "guanethidine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02C",
            "level3_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
            "level4": "C02CC",
            "level4_description": "Guanidine derivatives",
            "level5": "C02CC03",
            "who_name": "guanoxan"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02C",
            "level3_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
            "level4": "C02CC",
            "level4_description": "Guanidine derivatives",
            "level5": "C02CC04",
            "who_name": "debrisoquine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02C",
            "level3_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
            "level4": "C02CC",
            "level4_description": "Guanidine derivatives",
            "level5": "C02CC05",
            "who_name": "guanoclor"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02C",
            "level3_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
            "level4": "C02CC",
            "level4_description": "Guanidine derivatives",
            "level5": "C02CC06",
            "who_name": "guanazodine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02C",
            "level3_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
            "level4": "C02CC",
            "level4_description": "Guanidine derivatives",
            "level5": "C02CC07",
            "who_name": "guanoxabenz"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02D",
            "level3_description": "ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON",
            "level4": "C02DA",
            "level4_description": "Thiazide derivatives",
            "level5": "C02DA01",
            "who_name": "diazoxide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02D",
            "level3_description": "ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON",
            "level4": "C02DB",
            "level4_description": "Hydrazinophthalazine derivatives",
            "level5": "C02DB01",
            "who_name": "dihydralazine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02D",
            "level3_description": "ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON",
            "level4": "C02DB",
            "level4_description": "Hydrazinophthalazine derivatives",
            "level5": "C02DB02",
            "who_name": "hydralazine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02D",
            "level3_description": "ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON",
            "level4": "C02DB",
            "level4_description": "Hydrazinophthalazine derivatives",
            "level5": "C02DB03",
            "who_name": "endralazine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02D",
            "level3_description": "ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON",
            "level4": "C02DB",
            "level4_description": "Hydrazinophthalazine derivatives",
            "level5": "C02DB04",
            "who_name": "cadralazine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02D",
            "level3_description": "ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON",
            "level4": "C02DC",
            "level4_description": "Pyrimidine derivatives",
            "level5": "C02DC01",
            "who_name": "minoxidil"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02D",
            "level3_description": "ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON",
            "level4": "C02DD",
            "level4_description": "Nitroferricyanide derivatives",
            "level5": "C02DD01",
            "who_name": "nitroprusside"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02D",
            "level3_description": "ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON",
            "level4": "C02DG",
            "level4_description": "Guanidine derivatives",
            "level5": "C02DG01",
            "who_name": "pinacidil"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02K",
            "level3_description": "OTHER ANTIHYPERTENSIVES",
            "level4": "C02KA",
            "level4_description": "Alkaloids, excl. rauwolfia",
            "level5": "C02KA01",
            "who_name": "veratrum"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02K",
            "level3_description": "OTHER ANTIHYPERTENSIVES",
            "level4": "C02KB",
            "level4_description": "Tyrosine hydroxylase inhibitors",
            "level5": "C02KB01",
            "who_name": "metirosine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02K",
            "level3_description": "OTHER ANTIHYPERTENSIVES",
            "level4": "C02KC",
            "level4_description": "MAO inhibitors",
            "level5": "C02KC01",
            "who_name": "pargyline"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02K",
            "level3_description": "OTHER ANTIHYPERTENSIVES",
            "level4": "C02KD",
            "level4_description": "Serotonin antagonists",
            "level5": "C02KD01",
            "who_name": "ketanserin"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02K",
            "level3_description": "OTHER ANTIHYPERTENSIVES",
            "level4": "C02KX",
            "level4_description": "Antihypertensives for pulmonary arterial hypertension",
            "level5": "C02KX01",
            "who_name": "bosentan"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02K",
            "level3_description": "OTHER ANTIHYPERTENSIVES",
            "level4": "C02KX",
            "level4_description": "Antihypertensives for pulmonary arterial hypertension",
            "level5": "C02KX02",
            "who_name": "ambrisentan"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02K",
            "level3_description": "OTHER ANTIHYPERTENSIVES",
            "level4": "C02KX",
            "level4_description": "Antihypertensives for pulmonary arterial hypertension",
            "level5": "C02KX03",
            "who_name": "sitaxentan"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02K",
            "level3_description": "OTHER ANTIHYPERTENSIVES",
            "level4": "C02KX",
            "level4_description": "Antihypertensives for pulmonary arterial hypertension",
            "level5": "C02KX04",
            "who_name": "macitentan"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02K",
            "level3_description": "OTHER ANTIHYPERTENSIVES",
            "level4": "C02KX",
            "level4_description": "Antihypertensives for pulmonary arterial hypertension",
            "level5": "C02KX05",
            "who_name": "riociguat"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02K",
            "level3_description": "OTHER ANTIHYPERTENSIVES",
            "level4": "C02KX",
            "level4_description": "Antihypertensives for pulmonary arterial hypertension",
            "level5": "C02KX52",
            "who_name": "ambrisentan and tadalafil"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02L",
            "level3_description": "ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",
            "level4": "C02LA",
            "level4_description": "Rauwolfia alkaloids and diuretics in combination",
            "level5": "C02LA01",
            "who_name": "reserpine and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02L",
            "level3_description": "ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",
            "level4": "C02LA",
            "level4_description": "Rauwolfia alkaloids and diuretics in combination",
            "level5": "C02LA02",
            "who_name": "rescinnamine and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02L",
            "level3_description": "ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",
            "level4": "C02LA",
            "level4_description": "Rauwolfia alkaloids and diuretics in combination",
            "level5": "C02LA03",
            "who_name": "deserpidine and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02L",
            "level3_description": "ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",
            "level4": "C02LA",
            "level4_description": "Rauwolfia alkaloids and diuretics in combination",
            "level5": "C02LA04",
            "who_name": "methoserpidine and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02L",
            "level3_description": "ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",
            "level4": "C02LA",
            "level4_description": "Rauwolfia alkaloids and diuretics in combination",
            "level5": "C02LA07",
            "who_name": "bietaserpine and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02L",
            "level3_description": "ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",
            "level4": "C02LA",
            "level4_description": "Rauwolfia alkaloids and diuretics in combination",
            "level5": "C02LA08",
            "who_name": "rauwolfia alkaloids, whole root and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02L",
            "level3_description": "ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",
            "level4": "C02LA",
            "level4_description": "Rauwolfia alkaloids and diuretics in combination",
            "level5": "C02LA09",
            "who_name": "syrosingopine and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02L",
            "level3_description": "ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",
            "level4": "C02LA",
            "level4_description": "Rauwolfia alkaloids and diuretics in combination",
            "level5": "C02LA50",
            "who_name": "combination of rauwolfia alkaloids and diuretics incl. other combinations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02L",
            "level3_description": "ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",
            "level4": "C02LA",
            "level4_description": "Rauwolfia alkaloids and diuretics in combination",
            "level5": "C02LA51",
            "who_name": "reserpine and diuretics, combinations with other drugs"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02L",
            "level3_description": "ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",
            "level4": "C02LA",
            "level4_description": "Rauwolfia alkaloids and diuretics in combination",
            "level5": "C02LA52",
            "who_name": "rescinnamine and diuretics, combinations with other drugs"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02L",
            "level3_description": "ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",
            "level4": "C02LA",
            "level4_description": "Rauwolfia alkaloids and diuretics in combination",
            "level5": "C02LA71",
            "who_name": "reserpine and diuretics, combinations with psycholeptics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02L",
            "level3_description": "ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",
            "level4": "C02LB",
            "level4_description": "Methyldopa and diuretics in combination",
            "level5": "C02LB01",
            "who_name": "methyldopa (levorotatory) and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02L",
            "level3_description": "ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",
            "level4": "C02LC",
            "level4_description": "Imidazoline receptor agonists in combination with diuretics",
            "level5": "C02LC01",
            "who_name": "clonidine and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02L",
            "level3_description": "ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",
            "level4": "C02LC",
            "level4_description": "Imidazoline receptor agonists in combination with diuretics",
            "level5": "C02LC05",
            "who_name": "moxonidine and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02L",
            "level3_description": "ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",
            "level4": "C02LC",
            "level4_description": "Imidazoline receptor agonists in combination with diuretics",
            "level5": "C02LC51",
            "who_name": "clonidine and diuretics, combinations with other drugs"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02L",
            "level3_description": "ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",
            "level4": "C02LE",
            "level4_description": "Alpha-adrenoreceptor antagonists and diuretics",
            "level5": "C02LE01",
            "who_name": "prazosin and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02L",
            "level3_description": "ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",
            "level4": "C02LF",
            "level4_description": "Guanidine derivatives and diuretics",
            "level5": "C02LF01",
            "who_name": "guanethidine and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02L",
            "level3_description": "ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",
            "level4": "C02LG",
            "level4_description": "Hydrazinophthalazine derivatives and diuretics",
            "level5": "C02LG01",
            "who_name": "dihydralazine and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02L",
            "level3_description": "ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",
            "level4": "C02LG",
            "level4_description": "Hydrazinophthalazine derivatives and diuretics",
            "level5": "C02LG02",
            "who_name": "hydralazine and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02L",
            "level3_description": "ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",
            "level4": "C02LG",
            "level4_description": "Hydrazinophthalazine derivatives and diuretics",
            "level5": "C02LG03",
            "who_name": "picodralazine and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02L",
            "level3_description": "ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",
            "level4": "C02LG",
            "level4_description": "Hydrazinophthalazine derivatives and diuretics",
            "level5": "C02LG51",
            "who_name": "dihydralazine and diuretics, combinations with other drugs"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02L",
            "level3_description": "ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",
            "level4": "C02LG",
            "level4_description": "Hydrazinophthalazine derivatives and diuretics",
            "level5": "C02LG73",
            "who_name": "picodralazine and diuretics, combinations with psycholeptics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02L",
            "level3_description": "ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",
            "level4": "C02LK",
            "level4_description": "Alkaloids, excl. rauwolfia, in combination with diuretics",
            "level5": "C02LK01",
            "who_name": "veratrum and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02L",
            "level3_description": "ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",
            "level4": "C02LL",
            "level4_description": "MAO inhibitors and diuretics",
            "level5": "C02LL01",
            "who_name": "pargyline and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C02",
            "level2_description": "ANTIHYPERTENSIVES",
            "level3": "C02L",
            "level3_description": "ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",
            "level4": "C02LX",
            "level4_description": "Other antihypertensives and diuretics",
            "level5": "C02LX01",
            "who_name": "pinacidil and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03A",
            "level3_description": "LOW-CEILING DIURETICS, THIAZIDES",
            "level4": "C03AA",
            "level4_description": "Thiazides, plain",
            "level5": "C03AA01",
            "who_name": "bendroflumethiazide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03A",
            "level3_description": "LOW-CEILING DIURETICS, THIAZIDES",
            "level4": "C03AA",
            "level4_description": "Thiazides, plain",
            "level5": "C03AA02",
            "who_name": "hydroflumethiazide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03A",
            "level3_description": "LOW-CEILING DIURETICS, THIAZIDES",
            "level4": "C03AA",
            "level4_description": "Thiazides, plain",
            "level5": "C03AA03",
            "who_name": "hydrochlorothiazide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03A",
            "level3_description": "LOW-CEILING DIURETICS, THIAZIDES",
            "level4": "C03AA",
            "level4_description": "Thiazides, plain",
            "level5": "C03AA04",
            "who_name": "chlorothiazide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03A",
            "level3_description": "LOW-CEILING DIURETICS, THIAZIDES",
            "level4": "C03AA",
            "level4_description": "Thiazides, plain",
            "level5": "C03AA05",
            "who_name": "polythiazide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03A",
            "level3_description": "LOW-CEILING DIURETICS, THIAZIDES",
            "level4": "C03AA",
            "level4_description": "Thiazides, plain",
            "level5": "C03AA06",
            "who_name": "trichlormethiazide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03A",
            "level3_description": "LOW-CEILING DIURETICS, THIAZIDES",
            "level4": "C03AA",
            "level4_description": "Thiazides, plain",
            "level5": "C03AA07",
            "who_name": "cyclopenthiazide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03A",
            "level3_description": "LOW-CEILING DIURETICS, THIAZIDES",
            "level4": "C03AA",
            "level4_description": "Thiazides, plain",
            "level5": "C03AA08",
            "who_name": "methyclothiazide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03A",
            "level3_description": "LOW-CEILING DIURETICS, THIAZIDES",
            "level4": "C03AA",
            "level4_description": "Thiazides, plain",
            "level5": "C03AA09",
            "who_name": "cyclothiazide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03A",
            "level3_description": "LOW-CEILING DIURETICS, THIAZIDES",
            "level4": "C03AA",
            "level4_description": "Thiazides, plain",
            "level5": "C03AA13",
            "who_name": "mebutizide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03A",
            "level3_description": "LOW-CEILING DIURETICS, THIAZIDES",
            "level4": "C03AB",
            "level4_description": "Thiazides and potassium in combination",
            "level5": "C03AB01",
            "who_name": "bendroflumethiazide and potassium"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03A",
            "level3_description": "LOW-CEILING DIURETICS, THIAZIDES",
            "level4": "C03AB",
            "level4_description": "Thiazides and potassium in combination",
            "level5": "C03AB02",
            "who_name": "hydroflumethiazide and potassium"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03A",
            "level3_description": "LOW-CEILING DIURETICS, THIAZIDES",
            "level4": "C03AB",
            "level4_description": "Thiazides and potassium in combination",
            "level5": "C03AB03",
            "who_name": "hydrochlorothiazide and potassium"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03A",
            "level3_description": "LOW-CEILING DIURETICS, THIAZIDES",
            "level4": "C03AB",
            "level4_description": "Thiazides and potassium in combination",
            "level5": "C03AB04",
            "who_name": "chlorothiazide and potassium"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03A",
            "level3_description": "LOW-CEILING DIURETICS, THIAZIDES",
            "level4": "C03AB",
            "level4_description": "Thiazides and potassium in combination",
            "level5": "C03AB05",
            "who_name": "polythiazide and potassium"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03A",
            "level3_description": "LOW-CEILING DIURETICS, THIAZIDES",
            "level4": "C03AB",
            "level4_description": "Thiazides and potassium in combination",
            "level5": "C03AB06",
            "who_name": "trichlormethiazide and potassium"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03A",
            "level3_description": "LOW-CEILING DIURETICS, THIAZIDES",
            "level4": "C03AB",
            "level4_description": "Thiazides and potassium in combination",
            "level5": "C03AB07",
            "who_name": "cyclopenthiazide and potassium"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03A",
            "level3_description": "LOW-CEILING DIURETICS, THIAZIDES",
            "level4": "C03AB",
            "level4_description": "Thiazides and potassium in combination",
            "level5": "C03AB08",
            "who_name": "methyclothiazide and potassium"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03A",
            "level3_description": "LOW-CEILING DIURETICS, THIAZIDES",
            "level4": "C03AB",
            "level4_description": "Thiazides and potassium in combination",
            "level5": "C03AB09",
            "who_name": "cyclothiazide and potassium"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03A",
            "level3_description": "LOW-CEILING DIURETICS, THIAZIDES",
            "level4": "C03AH",
            "level4_description": "Thiazides, combinations with psycholeptics and/or analgesics",
            "level5": "C03AH01",
            "who_name": "chlorothiazide, combinations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03A",
            "level3_description": "LOW-CEILING DIURETICS, THIAZIDES",
            "level4": "C03AH",
            "level4_description": "Thiazides, combinations with psycholeptics and/or analgesics",
            "level5": "C03AH02",
            "who_name": "hydroflumethiazide, combinations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03A",
            "level3_description": "LOW-CEILING DIURETICS, THIAZIDES",
            "level4": "C03AX",
            "level4_description": "Thiazides, combinations with other drugs",
            "level5": "C03AX01",
            "who_name": "hydrochlorothiazide, combinations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03B",
            "level3_description": "LOW-CEILING DIURETICS, EXCL. THIAZIDES",
            "level4": "C03BA",
            "level4_description": "Sulfonamides, plain",
            "level5": "C03BA02",
            "who_name": "quinethazone"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03B",
            "level3_description": "LOW-CEILING DIURETICS, EXCL. THIAZIDES",
            "level4": "C03BA",
            "level4_description": "Sulfonamides, plain",
            "level5": "C03BA03",
            "who_name": "clopamide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03B",
            "level3_description": "LOW-CEILING DIURETICS, EXCL. THIAZIDES",
            "level4": "C03BA",
            "level4_description": "Sulfonamides, plain",
            "level5": "C03BA04",
            "who_name": "chlortalidone"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03B",
            "level3_description": "LOW-CEILING DIURETICS, EXCL. THIAZIDES",
            "level4": "C03BA",
            "level4_description": "Sulfonamides, plain",
            "level5": "C03BA05",
            "who_name": "mefruside"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03B",
            "level3_description": "LOW-CEILING DIURETICS, EXCL. THIAZIDES",
            "level4": "C03BA",
            "level4_description": "Sulfonamides, plain",
            "level5": "C03BA07",
            "who_name": "clofenamide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03B",
            "level3_description": "LOW-CEILING DIURETICS, EXCL. THIAZIDES",
            "level4": "C03BA",
            "level4_description": "Sulfonamides, plain",
            "level5": "C03BA08",
            "who_name": "metolazone"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03B",
            "level3_description": "LOW-CEILING DIURETICS, EXCL. THIAZIDES",
            "level4": "C03BA",
            "level4_description": "Sulfonamides, plain",
            "level5": "C03BA09",
            "who_name": "meticrane"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03B",
            "level3_description": "LOW-CEILING DIURETICS, EXCL. THIAZIDES",
            "level4": "C03BA",
            "level4_description": "Sulfonamides, plain",
            "level5": "C03BA10",
            "who_name": "xipamide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03B",
            "level3_description": "LOW-CEILING DIURETICS, EXCL. THIAZIDES",
            "level4": "C03BA",
            "level4_description": "Sulfonamides, plain",
            "level5": "C03BA11",
            "who_name": "indapamide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03B",
            "level3_description": "LOW-CEILING DIURETICS, EXCL. THIAZIDES",
            "level4": "C03BA",
            "level4_description": "Sulfonamides, plain",
            "level5": "C03BA12",
            "who_name": "clorexolone"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03B",
            "level3_description": "LOW-CEILING DIURETICS, EXCL. THIAZIDES",
            "level4": "C03BA",
            "level4_description": "Sulfonamides, plain",
            "level5": "C03BA13",
            "who_name": "fenquizone"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03B",
            "level3_description": "LOW-CEILING DIURETICS, EXCL. THIAZIDES",
            "level4": "C03BA",
            "level4_description": "Sulfonamides, plain",
            "level5": "C03BA82",
            "who_name": "clorexolone, combinations with psycholeptics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03B",
            "level3_description": "LOW-CEILING DIURETICS, EXCL. THIAZIDES",
            "level4": "C03BB",
            "level4_description": "Sulfonamides and potassium in combination",
            "level5": "C03BB02",
            "who_name": "quinethazone and potassium"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03B",
            "level3_description": "LOW-CEILING DIURETICS, EXCL. THIAZIDES",
            "level4": "C03BB",
            "level4_description": "Sulfonamides and potassium in combination",
            "level5": "C03BB03",
            "who_name": "clopamide and potassium"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03B",
            "level3_description": "LOW-CEILING DIURETICS, EXCL. THIAZIDES",
            "level4": "C03BB",
            "level4_description": "Sulfonamides and potassium in combination",
            "level5": "C03BB04",
            "who_name": "chlortalidone and potassium"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03B",
            "level3_description": "LOW-CEILING DIURETICS, EXCL. THIAZIDES",
            "level4": "C03BB",
            "level4_description": "Sulfonamides and potassium in combination",
            "level5": "C03BB05",
            "who_name": "mefruside and potassium"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03B",
            "level3_description": "LOW-CEILING DIURETICS, EXCL. THIAZIDES",
            "level4": "C03BB",
            "level4_description": "Sulfonamides and potassium in combination",
            "level5": "C03BB07",
            "who_name": "clofenamide and potassium"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03B",
            "level3_description": "LOW-CEILING DIURETICS, EXCL. THIAZIDES",
            "level4": "C03BC",
            "level4_description": "Mercurial diuretics",
            "level5": "C03BC01",
            "who_name": "mersalyl"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03B",
            "level3_description": "LOW-CEILING DIURETICS, EXCL. THIAZIDES",
            "level4": "C03BD",
            "level4_description": "Xanthine derivatives",
            "level5": "C03BD01",
            "who_name": "theobromine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03B",
            "level3_description": "LOW-CEILING DIURETICS, EXCL. THIAZIDES",
            "level4": "C03BX",
            "level4_description": "Other low-ceiling diuretics",
            "level5": "C03BX03",
            "who_name": "cicletanine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03C",
            "level3_description": "HIGH-CEILING DIURETICS",
            "level4": "C03CA",
            "level4_description": "Sulfonamides, plain",
            "level5": "C03CA01",
            "who_name": "furosemide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03C",
            "level3_description": "HIGH-CEILING DIURETICS",
            "level4": "C03CA",
            "level4_description": "Sulfonamides, plain",
            "level5": "C03CA02",
            "who_name": "bumetanide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03C",
            "level3_description": "HIGH-CEILING DIURETICS",
            "level4": "C03CA",
            "level4_description": "Sulfonamides, plain",
            "level5": "C03CA03",
            "who_name": "piretanide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03C",
            "level3_description": "HIGH-CEILING DIURETICS",
            "level4": "C03CA",
            "level4_description": "Sulfonamides, plain",
            "level5": "C03CA04",
            "who_name": "torasemide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03C",
            "level3_description": "HIGH-CEILING DIURETICS",
            "level4": "C03CB",
            "level4_description": "Sulfonamides and potassium in combination",
            "level5": "C03CB01",
            "who_name": "furosemide and potassium"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03C",
            "level3_description": "HIGH-CEILING DIURETICS",
            "level4": "C03CB",
            "level4_description": "Sulfonamides and potassium in combination",
            "level5": "C03CB02",
            "who_name": "bumetanide and potassium"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03C",
            "level3_description": "HIGH-CEILING DIURETICS",
            "level4": "C03CC",
            "level4_description": "Aryloxyacetic acid derivatives",
            "level5": "C03CC01",
            "who_name": "etacrynic acid"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03C",
            "level3_description": "HIGH-CEILING DIURETICS",
            "level4": "C03CC",
            "level4_description": "Aryloxyacetic acid derivatives",
            "level5": "C03CC02",
            "who_name": "tienilic acid"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03C",
            "level3_description": "HIGH-CEILING DIURETICS",
            "level4": "C03CD",
            "level4_description": "Pyrazolone derivatives",
            "level5": "C03CD01",
            "who_name": "muzolimine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03C",
            "level3_description": "HIGH-CEILING DIURETICS",
            "level4": "C03CX",
            "level4_description": "Other high-ceiling diuretics",
            "level5": "C03CX01",
            "who_name": "etozolin"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03D",
            "level3_description": "ALDOSTERONE ANTAGONISTS AND OTHER POTASSIUM-SPARING AGENTS",
            "level4": "C03DA",
            "level4_description": "Aldosterone antagonists",
            "level5": "C03DA01",
            "who_name": "spironolactone"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03D",
            "level3_description": "ALDOSTERONE ANTAGONISTS AND OTHER POTASSIUM-SPARING AGENTS",
            "level4": "C03DA",
            "level4_description": "Aldosterone antagonists",
            "level5": "C03DA02",
            "who_name": "potassium canrenoate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03D",
            "level3_description": "ALDOSTERONE ANTAGONISTS AND OTHER POTASSIUM-SPARING AGENTS",
            "level4": "C03DA",
            "level4_description": "Aldosterone antagonists",
            "level5": "C03DA03",
            "who_name": "canrenone"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03D",
            "level3_description": "ALDOSTERONE ANTAGONISTS AND OTHER POTASSIUM-SPARING AGENTS",
            "level4": "C03DA",
            "level4_description": "Aldosterone antagonists",
            "level5": "C03DA04",
            "who_name": "eplerenone"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03D",
            "level3_description": "ALDOSTERONE ANTAGONISTS AND OTHER POTASSIUM-SPARING AGENTS",
            "level4": "C03DA",
            "level4_description": "Aldosterone antagonists",
            "level5": "C03DA05",
            "who_name": "finerenone"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03D",
            "level3_description": "ALDOSTERONE ANTAGONISTS AND OTHER POTASSIUM-SPARING AGENTS",
            "level4": "C03DB",
            "level4_description": "Other potassium-sparing agents",
            "level5": "C03DB01",
            "who_name": "amiloride"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03D",
            "level3_description": "ALDOSTERONE ANTAGONISTS AND OTHER POTASSIUM-SPARING AGENTS",
            "level4": "C03DB",
            "level4_description": "Other potassium-sparing agents",
            "level5": "C03DB02",
            "who_name": "triamterene"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03E",
            "level3_description": "DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION",
            "level4": "C03EA",
            "level4_description": "Low-ceiling diuretics and potassium-sparing agents",
            "level5": "C03EA01",
            "who_name": "hydrochlorothiazide and potassium-sparing agents"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03E",
            "level3_description": "DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION",
            "level4": "C03EA",
            "level4_description": "Low-ceiling diuretics and potassium-sparing agents",
            "level5": "C03EA02",
            "who_name": "trichlormethiazide and potassium-sparing agents"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03E",
            "level3_description": "DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION",
            "level4": "C03EA",
            "level4_description": "Low-ceiling diuretics and potassium-sparing agents",
            "level5": "C03EA03",
            "who_name": "epitizide and potassium-sparing agents"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03E",
            "level3_description": "DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION",
            "level4": "C03EA",
            "level4_description": "Low-ceiling diuretics and potassium-sparing agents",
            "level5": "C03EA04",
            "who_name": "altizide and potassium-sparing agents"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03E",
            "level3_description": "DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION",
            "level4": "C03EA",
            "level4_description": "Low-ceiling diuretics and potassium-sparing agents",
            "level5": "C03EA05",
            "who_name": "mebutizide and potassium-sparing agents"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03E",
            "level3_description": "DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION",
            "level4": "C03EA",
            "level4_description": "Low-ceiling diuretics and potassium-sparing agents",
            "level5": "C03EA06",
            "who_name": "chlortalidone and potassium-sparing agents"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03E",
            "level3_description": "DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION",
            "level4": "C03EA",
            "level4_description": "Low-ceiling diuretics and potassium-sparing agents",
            "level5": "C03EA07",
            "who_name": "cyclopenthiazide and potassium-sparing agents"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03E",
            "level3_description": "DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION",
            "level4": "C03EA",
            "level4_description": "Low-ceiling diuretics and potassium-sparing agents",
            "level5": "C03EA12",
            "who_name": "metolazone and potassium-sparing agents"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03E",
            "level3_description": "DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION",
            "level4": "C03EA",
            "level4_description": "Low-ceiling diuretics and potassium-sparing agents",
            "level5": "C03EA13",
            "who_name": "bendroflumethiazide and potassium-sparing agents"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03E",
            "level3_description": "DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION",
            "level4": "C03EA",
            "level4_description": "Low-ceiling diuretics and potassium-sparing agents",
            "level5": "C03EA14",
            "who_name": "butizide and potassium-sparing agents"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03E",
            "level3_description": "DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION",
            "level4": "C03EB",
            "level4_description": "High-ceiling diuretics and potassium-sparing agents",
            "level5": "C03EB01",
            "who_name": "furosemide and potassium-sparing agents"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03E",
            "level3_description": "DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION",
            "level4": "C03EB",
            "level4_description": "High-ceiling diuretics and potassium-sparing agents",
            "level5": "C03EB02",
            "who_name": "bumetanide and potassium-sparing agents"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03X",
            "level3_description": "OTHER DIURETICS",
            "level4": "C03XA",
            "level4_description": "Vasopressin antagonists",
            "level5": "C03XA01",
            "who_name": "tolvaptan"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C03",
            "level2_description": "DIURETICS",
            "level3": "C03X",
            "level3_description": "OTHER DIURETICS",
            "level4": "C03XA",
            "level4_description": "Vasopressin antagonists",
            "level5": "C03XA02",
            "who_name": "conivaptan"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AA",
            "level4_description": "2-amino-1-phenylethanol derivatives",
            "level5": "C04AA01",
            "who_name": "isoxsuprine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AA",
            "level4_description": "2-amino-1-phenylethanol derivatives",
            "level5": "C04AA02",
            "who_name": "buphenine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AA",
            "level4_description": "2-amino-1-phenylethanol derivatives",
            "level5": "C04AA31",
            "who_name": "bamethan"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AB",
            "level4_description": "Imidazoline derivatives",
            "level5": "C04AB01",
            "who_name": "phentolamine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AB",
            "level4_description": "Imidazoline derivatives",
            "level5": "C04AB02",
            "who_name": "tolazoline"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AC",
            "level4_description": "Nicotinic acid and derivatives",
            "level5": "C04AC01",
            "who_name": "nicotinic acid"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AC",
            "level4_description": "Nicotinic acid and derivatives",
            "level5": "C04AC02",
            "who_name": "nicotinyl alcohol (pyridylcarbinol)"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AC",
            "level4_description": "Nicotinic acid and derivatives",
            "level5": "C04AC03",
            "who_name": "inositol nicotinate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AC",
            "level4_description": "Nicotinic acid and derivatives",
            "level5": "C04AC07",
            "who_name": "ciclonicate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AD",
            "level4_description": "Purine derivatives",
            "level5": "C04AD01",
            "who_name": "pentifylline"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AD",
            "level4_description": "Purine derivatives",
            "level5": "C04AD02",
            "who_name": "xantinol nicotinate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AD",
            "level4_description": "Purine derivatives",
            "level5": "C04AD03",
            "who_name": "pentoxifylline"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AD",
            "level4_description": "Purine derivatives",
            "level5": "C04AD04",
            "who_name": "etofylline nicotinate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AE",
            "level4_description": "Ergot alkaloids",
            "level5": "C04AE01",
            "who_name": "ergoloid mesylates"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AE",
            "level4_description": "Ergot alkaloids",
            "level5": "C04AE02",
            "who_name": "nicergoline"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AE",
            "level4_description": "Ergot alkaloids",
            "level5": "C04AE04",
            "who_name": "dihydroergocristine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AE",
            "level4_description": "Ergot alkaloids",
            "level5": "C04AE51",
            "who_name": "ergoloid mesylates, combinations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AE",
            "level4_description": "Ergot alkaloids",
            "level5": "C04AE54",
            "who_name": "dihydroergocristine, combinations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AF",
            "level4_description": "Enzymes",
            "level5": "C04AF01",
            "who_name": "kallidinogenase"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AX",
            "level4_description": "Other peripheral vasodilators",
            "level5": "C04AX01",
            "who_name": "cyclandelate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AX",
            "level4_description": "Other peripheral vasodilators",
            "level5": "C04AX02",
            "who_name": "phenoxybenzamine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AX",
            "level4_description": "Other peripheral vasodilators",
            "level5": "C04AX07",
            "who_name": "vincamine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AX",
            "level4_description": "Other peripheral vasodilators",
            "level5": "C04AX10",
            "who_name": "moxisylyte"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AX",
            "level4_description": "Other peripheral vasodilators",
            "level5": "C04AX11",
            "who_name": "bencyclane"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AX",
            "level4_description": "Other peripheral vasodilators",
            "level5": "C04AX17",
            "who_name": "vinburnine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AX",
            "level4_description": "Other peripheral vasodilators",
            "level5": "C04AX19",
            "who_name": "suloctidil"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AX",
            "level4_description": "Other peripheral vasodilators",
            "level5": "C04AX20",
            "who_name": "buflomedil"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AX",
            "level4_description": "Other peripheral vasodilators",
            "level5": "C04AX21",
            "who_name": "naftidrofuryl"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AX",
            "level4_description": "Other peripheral vasodilators",
            "level5": "C04AX23",
            "who_name": "butalamine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AX",
            "level4_description": "Other peripheral vasodilators",
            "level5": "C04AX24",
            "who_name": "visnadine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AX",
            "level4_description": "Other peripheral vasodilators",
            "level5": "C04AX26",
            "who_name": "cetiedil"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AX",
            "level4_description": "Other peripheral vasodilators",
            "level5": "C04AX27",
            "who_name": "cinepazide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AX",
            "level4_description": "Other peripheral vasodilators",
            "level5": "C04AX28",
            "who_name": "ifenprodil"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AX",
            "level4_description": "Other peripheral vasodilators",
            "level5": "C04AX30",
            "who_name": "azapetine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C04",
            "level2_description": "PERIPHERAL VASODILATORS",
            "level3": "C04A",
            "level3_description": "PERIPHERAL VASODILATORS",
            "level4": "C04AX",
            "level4_description": "Other peripheral vasodilators",
            "level5": "C04AX32",
            "who_name": "fasudil"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05A",
            "level3_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
            "level4": "C05AA",
            "level4_description": "Corticosteroids",
            "level5": "C05AA01",
            "who_name": "hydrocortisone"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05A",
            "level3_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
            "level4": "C05AA",
            "level4_description": "Corticosteroids",
            "level5": "C05AA04",
            "who_name": "prednisolone"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05A",
            "level3_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
            "level4": "C05AA",
            "level4_description": "Corticosteroids",
            "level5": "C05AA05",
            "who_name": "betamethasone"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05A",
            "level3_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
            "level4": "C05AA",
            "level4_description": "Corticosteroids",
            "level5": "C05AA06",
            "who_name": "fluorometholone"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05A",
            "level3_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
            "level4": "C05AA",
            "level4_description": "Corticosteroids",
            "level5": "C05AA08",
            "who_name": "fluocortolone"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05A",
            "level3_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
            "level4": "C05AA",
            "level4_description": "Corticosteroids",
            "level5": "C05AA09",
            "who_name": "dexamethasone"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05A",
            "level3_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
            "level4": "C05AA",
            "level4_description": "Corticosteroids",
            "level5": "C05AA10",
            "who_name": "fluocinolone acetonide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05A",
            "level3_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
            "level4": "C05AA",
            "level4_description": "Corticosteroids",
            "level5": "C05AA11",
            "who_name": "fluocinonide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05A",
            "level3_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
            "level4": "C05AA",
            "level4_description": "Corticosteroids",
            "level5": "C05AA12",
            "who_name": "triamcinolone"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05A",
            "level3_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
            "level4": "C05AD",
            "level4_description": "Local anesthetics",
            "level5": "C05AD01",
            "who_name": "lidocaine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05A",
            "level3_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
            "level4": "C05AD",
            "level4_description": "Local anesthetics",
            "level5": "C05AD02",
            "who_name": "tetracaine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05A",
            "level3_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
            "level4": "C05AD",
            "level4_description": "Local anesthetics",
            "level5": "C05AD03",
            "who_name": "benzocaine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05A",
            "level3_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
            "level4": "C05AD",
            "level4_description": "Local anesthetics",
            "level5": "C05AD04",
            "who_name": "cinchocaine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05A",
            "level3_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
            "level4": "C05AD",
            "level4_description": "Local anesthetics",
            "level5": "C05AD05",
            "who_name": "procaine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05A",
            "level3_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
            "level4": "C05AD",
            "level4_description": "Local anesthetics",
            "level5": "C05AD06",
            "who_name": "oxetacaine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05A",
            "level3_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
            "level4": "C05AD",
            "level4_description": "Local anesthetics",
            "level5": "C05AD07",
            "who_name": "pramocaine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05A",
            "level3_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
            "level4": "C05AE",
            "level4_description": "Muscle relaxants",
            "level5": "C05AE01",
            "who_name": "glyceryl trinitrate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05A",
            "level3_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
            "level4": "C05AE",
            "level4_description": "Muscle relaxants",
            "level5": "C05AE02",
            "who_name": "isosorbide dinitrate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05A",
            "level3_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
            "level4": "C05AE",
            "level4_description": "Muscle relaxants",
            "level5": "C05AE03",
            "who_name": "diltiazem"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05A",
            "level3_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
            "level4": "C05AX",
            "level4_description": "Other agents for treatment of hemorrhoids and anal fissures for topical use",
            "level5": "C05AX01",
            "who_name": "aluminium preparations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05A",
            "level3_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
            "level4": "C05AX",
            "level4_description": "Other agents for treatment of hemorrhoids and anal fissures for topical use",
            "level5": "C05AX02",
            "who_name": "bismuth preparations, combinations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05A",
            "level3_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
            "level4": "C05AX",
            "level4_description": "Other agents for treatment of hemorrhoids and anal fissures for topical use",
            "level5": "C05AX03",
            "who_name": "other preparations, combinations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05A",
            "level3_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
            "level4": "C05AX",
            "level4_description": "Other agents for treatment of hemorrhoids and anal fissures for topical use",
            "level5": "C05AX04",
            "who_name": "zinc preparations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05A",
            "level3_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
            "level4": "C05AX",
            "level4_description": "Other agents for treatment of hemorrhoids and anal fissures for topical use",
            "level5": "C05AX05",
            "who_name": "tribenoside"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05B",
            "level3_description": "ANTIVARICOSE THERAPY",
            "level4": "C05BA",
            "level4_description": "Heparins or heparinoids for topical use",
            "level5": "C05BA01",
            "who_name": "organo-heparinoid"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05B",
            "level3_description": "ANTIVARICOSE THERAPY",
            "level4": "C05BA",
            "level4_description": "Heparins or heparinoids for topical use",
            "level5": "C05BA02",
            "who_name": "sodium apolate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05B",
            "level3_description": "ANTIVARICOSE THERAPY",
            "level4": "C05BA",
            "level4_description": "Heparins or heparinoids for topical use",
            "level5": "C05BA03",
            "who_name": "heparin"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05B",
            "level3_description": "ANTIVARICOSE THERAPY",
            "level4": "C05BA",
            "level4_description": "Heparins or heparinoids for topical use",
            "level5": "C05BA04",
            "who_name": "pentosan polysulfate sodium"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05B",
            "level3_description": "ANTIVARICOSE THERAPY",
            "level4": "C05BA",
            "level4_description": "Heparins or heparinoids for topical use",
            "level5": "C05BA51",
            "who_name": "heparinoid, combinations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05B",
            "level3_description": "ANTIVARICOSE THERAPY",
            "level4": "C05BA",
            "level4_description": "Heparins or heparinoids for topical use",
            "level5": "C05BA53",
            "who_name": "heparin, combinations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05B",
            "level3_description": "ANTIVARICOSE THERAPY",
            "level4": "C05BB",
            "level4_description": "Sclerosing agents for local injection",
            "level5": "C05BB01",
            "who_name": "monoethanolamine oleate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05B",
            "level3_description": "ANTIVARICOSE THERAPY",
            "level4": "C05BB",
            "level4_description": "Sclerosing agents for local injection",
            "level5": "C05BB02",
            "who_name": "polidocanol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05B",
            "level3_description": "ANTIVARICOSE THERAPY",
            "level4": "C05BB",
            "level4_description": "Sclerosing agents for local injection",
            "level5": "C05BB03",
            "who_name": "invert sugar"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05B",
            "level3_description": "ANTIVARICOSE THERAPY",
            "level4": "C05BB",
            "level4_description": "Sclerosing agents for local injection",
            "level5": "C05BB04",
            "who_name": "sodium tetradecyl sulfate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05B",
            "level3_description": "ANTIVARICOSE THERAPY",
            "level4": "C05BB",
            "level4_description": "Sclerosing agents for local injection",
            "level5": "C05BB05",
            "who_name": "phenol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05B",
            "level3_description": "ANTIVARICOSE THERAPY",
            "level4": "C05BB",
            "level4_description": "Sclerosing agents for local injection",
            "level5": "C05BB56",
            "who_name": "glucose, combinations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05B",
            "level3_description": "ANTIVARICOSE THERAPY",
            "level4": "C05BX",
            "level4_description": "Other sclerosing agents",
            "level5": "C05BX01",
            "who_name": "calcium dobesilate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05B",
            "level3_description": "ANTIVARICOSE THERAPY",
            "level4": "C05BX",
            "level4_description": "Other sclerosing agents",
            "level5": "C05BX51",
            "who_name": "calcium dobesilate, combinations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05C",
            "level3_description": "CAPILLARY STABILIZING AGENTS",
            "level4": "C05CA",
            "level4_description": "Bioflavonoids",
            "level5": "C05CA01",
            "who_name": "rutoside"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05C",
            "level3_description": "CAPILLARY STABILIZING AGENTS",
            "level4": "C05CA",
            "level4_description": "Bioflavonoids",
            "level5": "C05CA02",
            "who_name": "monoxerutin"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05C",
            "level3_description": "CAPILLARY STABILIZING AGENTS",
            "level4": "C05CA",
            "level4_description": "Bioflavonoids",
            "level5": "C05CA03",
            "who_name": "diosmin"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05C",
            "level3_description": "CAPILLARY STABILIZING AGENTS",
            "level4": "C05CA",
            "level4_description": "Bioflavonoids",
            "level5": "C05CA04",
            "who_name": "troxerutin"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05C",
            "level3_description": "CAPILLARY STABILIZING AGENTS",
            "level4": "C05CA",
            "level4_description": "Bioflavonoids",
            "level5": "C05CA05",
            "who_name": "hidrosmin"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05C",
            "level3_description": "CAPILLARY STABILIZING AGENTS",
            "level4": "C05CA",
            "level4_description": "Bioflavonoids",
            "level5": "C05CA51",
            "who_name": "rutoside, combinations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05C",
            "level3_description": "CAPILLARY STABILIZING AGENTS",
            "level4": "C05CA",
            "level4_description": "Bioflavonoids",
            "level5": "C05CA53",
            "who_name": "diosmin, combinations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05C",
            "level3_description": "CAPILLARY STABILIZING AGENTS",
            "level4": "C05CA",
            "level4_description": "Bioflavonoids",
            "level5": "C05CA54",
            "who_name": "troxerutin, combinations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05C",
            "level3_description": "CAPILLARY STABILIZING AGENTS",
            "level4": "C05CX",
            "level4_description": "Other capillary stabilizing agents",
            "level5": "C05CX01",
            "who_name": "tribenoside"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05C",
            "level3_description": "CAPILLARY STABILIZING AGENTS",
            "level4": "C05CX",
            "level4_description": "Other capillary stabilizing agents",
            "level5": "C05CX02",
            "who_name": "naftazone"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C05",
            "level2_description": "VASOPROTECTIVES",
            "level3": "C05C",
            "level3_description": "CAPILLARY STABILIZING AGENTS",
            "level4": "C05CX",
            "level4_description": "Other capillary stabilizing agents",
            "level5": "C05CX03",
            "who_name": "Hippocastani semen"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AA",
            "level4_description": "Beta blocking agents, non-selective",
            "level5": "C07AA01",
            "who_name": "alprenolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AA",
            "level4_description": "Beta blocking agents, non-selective",
            "level5": "C07AA02",
            "who_name": "oxprenolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AA",
            "level4_description": "Beta blocking agents, non-selective",
            "level5": "C07AA03",
            "who_name": "pindolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AA",
            "level4_description": "Beta blocking agents, non-selective",
            "level5": "C07AA05",
            "who_name": "propranolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AA",
            "level4_description": "Beta blocking agents, non-selective",
            "level5": "C07AA06",
            "who_name": "timolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AA",
            "level4_description": "Beta blocking agents, non-selective",
            "level5": "C07AA07",
            "who_name": "sotalol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AA",
            "level4_description": "Beta blocking agents, non-selective",
            "level5": "C07AA12",
            "who_name": "nadolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AA",
            "level4_description": "Beta blocking agents, non-selective",
            "level5": "C07AA14",
            "who_name": "mepindolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AA",
            "level4_description": "Beta blocking agents, non-selective",
            "level5": "C07AA15",
            "who_name": "carteolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AA",
            "level4_description": "Beta blocking agents, non-selective",
            "level5": "C07AA16",
            "who_name": "tertatolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AA",
            "level4_description": "Beta blocking agents, non-selective",
            "level5": "C07AA17",
            "who_name": "bopindolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AA",
            "level4_description": "Beta blocking agents, non-selective",
            "level5": "C07AA19",
            "who_name": "bupranolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AA",
            "level4_description": "Beta blocking agents, non-selective",
            "level5": "C07AA23",
            "who_name": "penbutolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AA",
            "level4_description": "Beta blocking agents, non-selective",
            "level5": "C07AA27",
            "who_name": "cloranolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AB",
            "level4_description": "Beta blocking agents, selective",
            "level5": "C07AB01",
            "who_name": "practolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AB",
            "level4_description": "Beta blocking agents, selective",
            "level5": "C07AB02",
            "who_name": "metoprolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AB",
            "level4_description": "Beta blocking agents, selective",
            "level5": "C07AB03",
            "who_name": "atenolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AB",
            "level4_description": "Beta blocking agents, selective",
            "level5": "C07AB04",
            "who_name": "acebutolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AB",
            "level4_description": "Beta blocking agents, selective",
            "level5": "C07AB05",
            "who_name": "betaxolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AB",
            "level4_description": "Beta blocking agents, selective",
            "level5": "C07AB06",
            "who_name": "bevantolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AB",
            "level4_description": "Beta blocking agents, selective",
            "level5": "C07AB07",
            "who_name": "bisoprolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AB",
            "level4_description": "Beta blocking agents, selective",
            "level5": "C07AB08",
            "who_name": "celiprolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AB",
            "level4_description": "Beta blocking agents, selective",
            "level5": "C07AB09",
            "who_name": "esmolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AB",
            "level4_description": "Beta blocking agents, selective",
            "level5": "C07AB10",
            "who_name": "epanolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AB",
            "level4_description": "Beta blocking agents, selective",
            "level5": "C07AB11",
            "who_name": "s-atenolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AB",
            "level4_description": "Beta blocking agents, selective",
            "level5": "C07AB12",
            "who_name": "nebivolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AB",
            "level4_description": "Beta blocking agents, selective",
            "level5": "C07AB13",
            "who_name": "talinolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AB",
            "level4_description": "Beta blocking agents, selective",
            "level5": "C07AB14",
            "who_name": "landiolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AG",
            "level4_description": "Alpha and beta blocking agents",
            "level5": "C07AG01",
            "who_name": "labetalol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07A",
            "level3_description": "BETA BLOCKING AGENTS",
            "level4": "C07AG",
            "level4_description": "Alpha and beta blocking agents",
            "level5": "C07AG02",
            "who_name": "carvedilol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07B",
            "level3_description": "BETA BLOCKING AGENTS AND THIAZIDES",
            "level4": "C07BA",
            "level4_description": "Beta blocking agents, non-selective, and thiazides",
            "level5": "C07BA02",
            "who_name": "oxprenolol and thiazides"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07B",
            "level3_description": "BETA BLOCKING AGENTS AND THIAZIDES",
            "level4": "C07BA",
            "level4_description": "Beta blocking agents, non-selective, and thiazides",
            "level5": "C07BA05",
            "who_name": "propranolol and thiazides"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07B",
            "level3_description": "BETA BLOCKING AGENTS AND THIAZIDES",
            "level4": "C07BA",
            "level4_description": "Beta blocking agents, non-selective, and thiazides",
            "level5": "C07BA06",
            "who_name": "timolol and thiazides"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07B",
            "level3_description": "BETA BLOCKING AGENTS AND THIAZIDES",
            "level4": "C07BA",
            "level4_description": "Beta blocking agents, non-selective, and thiazides",
            "level5": "C07BA07",
            "who_name": "sotalol and thiazides"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07B",
            "level3_description": "BETA BLOCKING AGENTS AND THIAZIDES",
            "level4": "C07BA",
            "level4_description": "Beta blocking agents, non-selective, and thiazides",
            "level5": "C07BA12",
            "who_name": "nadolol and thiazides"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07B",
            "level3_description": "BETA BLOCKING AGENTS AND THIAZIDES",
            "level4": "C07BA",
            "level4_description": "Beta blocking agents, non-selective, and thiazides",
            "level5": "C07BA68",
            "who_name": "metipranolol and thiazides, combinations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07B",
            "level3_description": "BETA BLOCKING AGENTS AND THIAZIDES",
            "level4": "C07BB",
            "level4_description": "Beta blocking agents, selective, and thiazides",
            "level5": "C07BB02",
            "who_name": "metoprolol and thiazides"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07B",
            "level3_description": "BETA BLOCKING AGENTS AND THIAZIDES",
            "level4": "C07BB",
            "level4_description": "Beta blocking agents, selective, and thiazides",
            "level5": "C07BB03",
            "who_name": "atenolol and thiazides"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07B",
            "level3_description": "BETA BLOCKING AGENTS AND THIAZIDES",
            "level4": "C07BB",
            "level4_description": "Beta blocking agents, selective, and thiazides",
            "level5": "C07BB04",
            "who_name": "acebutolol and thiazides"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07B",
            "level3_description": "BETA BLOCKING AGENTS AND THIAZIDES",
            "level4": "C07BB",
            "level4_description": "Beta blocking agents, selective, and thiazides",
            "level5": "C07BB06",
            "who_name": "bevantolol and thiazides"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07B",
            "level3_description": "BETA BLOCKING AGENTS AND THIAZIDES",
            "level4": "C07BB",
            "level4_description": "Beta blocking agents, selective, and thiazides",
            "level5": "C07BB07",
            "who_name": "bisoprolol and thiazides"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07B",
            "level3_description": "BETA BLOCKING AGENTS AND THIAZIDES",
            "level4": "C07BB",
            "level4_description": "Beta blocking agents, selective, and thiazides",
            "level5": "C07BB12",
            "who_name": "nebivolol and thiazides"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07B",
            "level3_description": "BETA BLOCKING AGENTS AND THIAZIDES",
            "level4": "C07BB",
            "level4_description": "Beta blocking agents, selective, and thiazides",
            "level5": "C07BB52",
            "who_name": "metoprolol and thiazides, combinations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07B",
            "level3_description": "BETA BLOCKING AGENTS AND THIAZIDES",
            "level4": "C07BG",
            "level4_description": "Alpha and beta blocking agents and thiazides",
            "level5": "C07BG01",
            "who_name": "labetalol and thiazides"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07C",
            "level3_description": "BETA BLOCKING AGENTS AND OTHER DIURETICS",
            "level4": "C07CA",
            "level4_description": "Beta blocking agents, non-selective, and other diuretics",
            "level5": "C07CA02",
            "who_name": "oxprenolol and other diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07C",
            "level3_description": "BETA BLOCKING AGENTS AND OTHER DIURETICS",
            "level4": "C07CA",
            "level4_description": "Beta blocking agents, non-selective, and other diuretics",
            "level5": "C07CA03",
            "who_name": "pindolol and other diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07C",
            "level3_description": "BETA BLOCKING AGENTS AND OTHER DIURETICS",
            "level4": "C07CA",
            "level4_description": "Beta blocking agents, non-selective, and other diuretics",
            "level5": "C07CA17",
            "who_name": "bopindolol and other diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07C",
            "level3_description": "BETA BLOCKING AGENTS AND OTHER DIURETICS",
            "level4": "C07CA",
            "level4_description": "Beta blocking agents, non-selective, and other diuretics",
            "level5": "C07CA23",
            "who_name": "penbutolol and other diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07C",
            "level3_description": "BETA BLOCKING AGENTS AND OTHER DIURETICS",
            "level4": "C07CB",
            "level4_description": "Beta blocking agents, selective, and other diuretics",
            "level5": "C07CB02",
            "who_name": "metoprolol and other diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07C",
            "level3_description": "BETA BLOCKING AGENTS AND OTHER DIURETICS",
            "level4": "C07CB",
            "level4_description": "Beta blocking agents, selective, and other diuretics",
            "level5": "C07CB03",
            "who_name": "atenolol and other diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07C",
            "level3_description": "BETA BLOCKING AGENTS AND OTHER DIURETICS",
            "level4": "C07CB",
            "level4_description": "Beta blocking agents, selective, and other diuretics",
            "level5": "C07CB53",
            "who_name": "atenolol and other diuretics, combinations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07C",
            "level3_description": "BETA BLOCKING AGENTS AND OTHER DIURETICS",
            "level4": "C07CG",
            "level4_description": "Alpha and beta blocking agents and other diuretics",
            "level5": "C07CG01",
            "who_name": "labetalol and other diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07D",
            "level3_description": "BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS",
            "level4": "C07DA",
            "level4_description": "Beta blocking agents, non-selective, thiazides and other diuretics",
            "level5": "C07DA06",
            "who_name": "timolol, thiazides and other diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07D",
            "level3_description": "BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS",
            "level4": "C07DB",
            "level4_description": "Beta blocking agents, selective, thiazides and other diuretics",
            "level5": "C07DB01",
            "who_name": "atenolol, thiazides and other diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07F",
            "level3_description": "BETA BLOCKING AGENTS, OTHER COMBINATIONS",
            "level4": "C07FB",
            "level4_description": "Beta blocking agents and calcium channel blockers",
            "level5": "C07FB02",
            "who_name": "metoprolol and felodipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07F",
            "level3_description": "BETA BLOCKING AGENTS, OTHER COMBINATIONS",
            "level4": "C07FB",
            "level4_description": "Beta blocking agents and calcium channel blockers",
            "level5": "C07FB03",
            "who_name": "atenolol and nifedipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07F",
            "level3_description": "BETA BLOCKING AGENTS, OTHER COMBINATIONS",
            "level4": "C07FB",
            "level4_description": "Beta blocking agents and calcium channel blockers",
            "level5": "C07FB07",
            "who_name": "bisoprolol and amlodipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07F",
            "level3_description": "BETA BLOCKING AGENTS, OTHER COMBINATIONS",
            "level4": "C07FB",
            "level4_description": "Beta blocking agents and calcium channel blockers",
            "level5": "C07FB12",
            "who_name": "nebivolol and amlodipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07F",
            "level3_description": "BETA BLOCKING AGENTS, OTHER COMBINATIONS",
            "level4": "C07FB",
            "level4_description": "Beta blocking agents and calcium channel blockers",
            "level5": "C07FB13",
            "who_name": "metoprolol and amlodipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07F",
            "level3_description": "BETA BLOCKING AGENTS, OTHER COMBINATIONS",
            "level4": "C07FX",
            "level4_description": "Beta blocking agents, other combinations",
            "level5": "C07FX01",
            "who_name": "propranolol and other combinations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07F",
            "level3_description": "BETA BLOCKING AGENTS, OTHER COMBINATIONS",
            "level4": "C07FX",
            "level4_description": "Beta blocking agents, other combinations",
            "level5": "C07FX02",
            "who_name": "sotalol and acetylsalicylic acid"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07F",
            "level3_description": "BETA BLOCKING AGENTS, OTHER COMBINATIONS",
            "level4": "C07FX",
            "level4_description": "Beta blocking agents, other combinations",
            "level5": "C07FX03",
            "who_name": "metoprolol and acetylsalicylic acid"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07F",
            "level3_description": "BETA BLOCKING AGENTS, OTHER COMBINATIONS",
            "level4": "C07FX",
            "level4_description": "Beta blocking agents, other combinations",
            "level5": "C07FX04",
            "who_name": "bisoprolol and acetylsalicylic acid"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07F",
            "level3_description": "BETA BLOCKING AGENTS, OTHER COMBINATIONS",
            "level4": "C07FX",
            "level4_description": "Beta blocking agents, other combinations",
            "level5": "C07FX05",
            "who_name": "metoprolol and ivabradine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C07",
            "level2_description": "BETA BLOCKING AGENTS",
            "level3": "C07F",
            "level3_description": "BETA BLOCKING AGENTS, OTHER COMBINATIONS",
            "level4": "C07FX",
            "level4_description": "Beta blocking agents, other combinations",
            "level5": "C07FX06",
            "who_name": "carvedilol and ivabradine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08C",
            "level3_description": "SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS",
            "level4": "C08CA",
            "level4_description": "Dihydropyridine derivatives",
            "level5": "C08CA01",
            "who_name": "amlodipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08C",
            "level3_description": "SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS",
            "level4": "C08CA",
            "level4_description": "Dihydropyridine derivatives",
            "level5": "C08CA02",
            "who_name": "felodipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08C",
            "level3_description": "SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS",
            "level4": "C08CA",
            "level4_description": "Dihydropyridine derivatives",
            "level5": "C08CA03",
            "who_name": "isradipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08C",
            "level3_description": "SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS",
            "level4": "C08CA",
            "level4_description": "Dihydropyridine derivatives",
            "level5": "C08CA04",
            "who_name": "nicardipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08C",
            "level3_description": "SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS",
            "level4": "C08CA",
            "level4_description": "Dihydropyridine derivatives",
            "level5": "C08CA05",
            "who_name": "nifedipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08C",
            "level3_description": "SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS",
            "level4": "C08CA",
            "level4_description": "Dihydropyridine derivatives",
            "level5": "C08CA06",
            "who_name": "nimodipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08C",
            "level3_description": "SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS",
            "level4": "C08CA",
            "level4_description": "Dihydropyridine derivatives",
            "level5": "C08CA07",
            "who_name": "nisoldipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08C",
            "level3_description": "SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS",
            "level4": "C08CA",
            "level4_description": "Dihydropyridine derivatives",
            "level5": "C08CA08",
            "who_name": "nitrendipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08C",
            "level3_description": "SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS",
            "level4": "C08CA",
            "level4_description": "Dihydropyridine derivatives",
            "level5": "C08CA09",
            "who_name": "lacidipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08C",
            "level3_description": "SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS",
            "level4": "C08CA",
            "level4_description": "Dihydropyridine derivatives",
            "level5": "C08CA10",
            "who_name": "nilvadipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08C",
            "level3_description": "SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS",
            "level4": "C08CA",
            "level4_description": "Dihydropyridine derivatives",
            "level5": "C08CA11",
            "who_name": "manidipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08C",
            "level3_description": "SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS",
            "level4": "C08CA",
            "level4_description": "Dihydropyridine derivatives",
            "level5": "C08CA12",
            "who_name": "barnidipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08C",
            "level3_description": "SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS",
            "level4": "C08CA",
            "level4_description": "Dihydropyridine derivatives",
            "level5": "C08CA13",
            "who_name": "lercanidipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08C",
            "level3_description": "SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS",
            "level4": "C08CA",
            "level4_description": "Dihydropyridine derivatives",
            "level5": "C08CA14",
            "who_name": "cilnidipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08C",
            "level3_description": "SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS",
            "level4": "C08CA",
            "level4_description": "Dihydropyridine derivatives",
            "level5": "C08CA15",
            "who_name": "benidipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08C",
            "level3_description": "SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS",
            "level4": "C08CA",
            "level4_description": "Dihydropyridine derivatives",
            "level5": "C08CA16",
            "who_name": "clevidipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08C",
            "level3_description": "SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS",
            "level4": "C08CA",
            "level4_description": "Dihydropyridine derivatives",
            "level5": "C08CA17",
            "who_name": "levamlodipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08C",
            "level3_description": "SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS",
            "level4": "C08CA",
            "level4_description": "Dihydropyridine derivatives",
            "level5": "C08CA51",
            "who_name": "amlodipine and celecoxib"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08C",
            "level3_description": "SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS",
            "level4": "C08CA",
            "level4_description": "Dihydropyridine derivatives",
            "level5": "C08CA55",
            "who_name": "nifedipine, combinations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08C",
            "level3_description": "SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS",
            "level4": "C08CX",
            "level4_description": "Other selective calcium channel blockers with mainly vascular effects",
            "level5": "C08CX01",
            "who_name": "mibefradil"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08D",
            "level3_description": "SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS",
            "level4": "C08DA",
            "level4_description": "Phenylalkylamine derivatives",
            "level5": "C08DA01",
            "who_name": "verapamil"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08D",
            "level3_description": "SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS",
            "level4": "C08DA",
            "level4_description": "Phenylalkylamine derivatives",
            "level5": "C08DA02",
            "who_name": "gallopamil"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08D",
            "level3_description": "SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS",
            "level4": "C08DA",
            "level4_description": "Phenylalkylamine derivatives",
            "level5": "C08DA51",
            "who_name": "verapamil, combinations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08D",
            "level3_description": "SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS",
            "level4": "C08DB",
            "level4_description": "Benzothiazepine derivatives",
            "level5": "C08DB01",
            "who_name": "diltiazem"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08E",
            "level3_description": "NON-SELECTIVE CALCIUM CHANNEL BLOCKERS",
            "level4": "C08EA",
            "level4_description": "Phenylalkylamine derivatives",
            "level5": "C08EA01",
            "who_name": "fendiline"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08E",
            "level3_description": "NON-SELECTIVE CALCIUM CHANNEL BLOCKERS",
            "level4": "C08EA",
            "level4_description": "Phenylalkylamine derivatives",
            "level5": "C08EA02",
            "who_name": "bepridil"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08E",
            "level3_description": "NON-SELECTIVE CALCIUM CHANNEL BLOCKERS",
            "level4": "C08EX",
            "level4_description": "Other non-selective calcium channel blockers",
            "level5": "C08EX01",
            "who_name": "lidoflazine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08E",
            "level3_description": "NON-SELECTIVE CALCIUM CHANNEL BLOCKERS",
            "level4": "C08EX",
            "level4_description": "Other non-selective calcium channel blockers",
            "level5": "C08EX02",
            "who_name": "perhexiline"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08G",
            "level3_description": "CALCIUM CHANNEL BLOCKERS AND DIURETICS",
            "level4": "C08GA",
            "level4_description": "Calcium channel blockers and diuretics",
            "level5": "C08GA01",
            "who_name": "nifedipine and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C08",
            "level2_description": "CALCIUM CHANNEL BLOCKERS",
            "level3": "C08G",
            "level3_description": "CALCIUM CHANNEL BLOCKERS AND DIURETICS",
            "level4": "C08GA",
            "level4_description": "Calcium channel blockers and diuretics",
            "level5": "C08GA02",
            "who_name": "amlodipine and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09A",
            "level3_description": "ACE INHIBITORS, PLAIN",
            "level4": "C09AA",
            "level4_description": "ACE inhibitors, plain",
            "level5": "C09AA01",
            "who_name": "captopril"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09A",
            "level3_description": "ACE INHIBITORS, PLAIN",
            "level4": "C09AA",
            "level4_description": "ACE inhibitors, plain",
            "level5": "C09AA02",
            "who_name": "enalapril"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09A",
            "level3_description": "ACE INHIBITORS, PLAIN",
            "level4": "C09AA",
            "level4_description": "ACE inhibitors, plain",
            "level5": "C09AA03",
            "who_name": "lisinopril"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09A",
            "level3_description": "ACE INHIBITORS, PLAIN",
            "level4": "C09AA",
            "level4_description": "ACE inhibitors, plain",
            "level5": "C09AA04",
            "who_name": "perindopril"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09A",
            "level3_description": "ACE INHIBITORS, PLAIN",
            "level4": "C09AA",
            "level4_description": "ACE inhibitors, plain",
            "level5": "C09AA05",
            "who_name": "ramipril"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09A",
            "level3_description": "ACE INHIBITORS, PLAIN",
            "level4": "C09AA",
            "level4_description": "ACE inhibitors, plain",
            "level5": "C09AA06",
            "who_name": "quinapril"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09A",
            "level3_description": "ACE INHIBITORS, PLAIN",
            "level4": "C09AA",
            "level4_description": "ACE inhibitors, plain",
            "level5": "C09AA07",
            "who_name": "benazepril"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09A",
            "level3_description": "ACE INHIBITORS, PLAIN",
            "level4": "C09AA",
            "level4_description": "ACE inhibitors, plain",
            "level5": "C09AA08",
            "who_name": "cilazapril"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09A",
            "level3_description": "ACE INHIBITORS, PLAIN",
            "level4": "C09AA",
            "level4_description": "ACE inhibitors, plain",
            "level5": "C09AA09",
            "who_name": "fosinopril"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09A",
            "level3_description": "ACE INHIBITORS, PLAIN",
            "level4": "C09AA",
            "level4_description": "ACE inhibitors, plain",
            "level5": "C09AA10",
            "who_name": "trandolapril"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09A",
            "level3_description": "ACE INHIBITORS, PLAIN",
            "level4": "C09AA",
            "level4_description": "ACE inhibitors, plain",
            "level5": "C09AA11",
            "who_name": "spirapril"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09A",
            "level3_description": "ACE INHIBITORS, PLAIN",
            "level4": "C09AA",
            "level4_description": "ACE inhibitors, plain",
            "level5": "C09AA12",
            "who_name": "delapril"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09A",
            "level3_description": "ACE INHIBITORS, PLAIN",
            "level4": "C09AA",
            "level4_description": "ACE inhibitors, plain",
            "level5": "C09AA13",
            "who_name": "moexipril"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09A",
            "level3_description": "ACE INHIBITORS, PLAIN",
            "level4": "C09AA",
            "level4_description": "ACE inhibitors, plain",
            "level5": "C09AA14",
            "who_name": "temocapril"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09A",
            "level3_description": "ACE INHIBITORS, PLAIN",
            "level4": "C09AA",
            "level4_description": "ACE inhibitors, plain",
            "level5": "C09AA15",
            "who_name": "zofenopril"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09A",
            "level3_description": "ACE INHIBITORS, PLAIN",
            "level4": "C09AA",
            "level4_description": "ACE inhibitors, plain",
            "level5": "C09AA16",
            "who_name": "imidapril"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09B",
            "level3_description": "ACE INHIBITORS, COMBINATIONS",
            "level4": "C09BA",
            "level4_description": "ACE inhibitors and diuretics",
            "level5": "C09BA01",
            "who_name": "captopril and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09B",
            "level3_description": "ACE INHIBITORS, COMBINATIONS",
            "level4": "C09BA",
            "level4_description": "ACE inhibitors and diuretics",
            "level5": "C09BA02",
            "who_name": "enalapril and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09B",
            "level3_description": "ACE INHIBITORS, COMBINATIONS",
            "level4": "C09BA",
            "level4_description": "ACE inhibitors and diuretics",
            "level5": "C09BA03",
            "who_name": "lisinopril and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09B",
            "level3_description": "ACE INHIBITORS, COMBINATIONS",
            "level4": "C09BA",
            "level4_description": "ACE inhibitors and diuretics",
            "level5": "C09BA04",
            "who_name": "perindopril and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09B",
            "level3_description": "ACE INHIBITORS, COMBINATIONS",
            "level4": "C09BA",
            "level4_description": "ACE inhibitors and diuretics",
            "level5": "C09BA05",
            "who_name": "ramipril and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09B",
            "level3_description": "ACE INHIBITORS, COMBINATIONS",
            "level4": "C09BA",
            "level4_description": "ACE inhibitors and diuretics",
            "level5": "C09BA06",
            "who_name": "quinapril and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09B",
            "level3_description": "ACE INHIBITORS, COMBINATIONS",
            "level4": "C09BA",
            "level4_description": "ACE inhibitors and diuretics",
            "level5": "C09BA07",
            "who_name": "benazepril and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09B",
            "level3_description": "ACE INHIBITORS, COMBINATIONS",
            "level4": "C09BA",
            "level4_description": "ACE inhibitors and diuretics",
            "level5": "C09BA08",
            "who_name": "cilazapril and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09B",
            "level3_description": "ACE INHIBITORS, COMBINATIONS",
            "level4": "C09BA",
            "level4_description": "ACE inhibitors and diuretics",
            "level5": "C09BA09",
            "who_name": "fosinopril and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09B",
            "level3_description": "ACE INHIBITORS, COMBINATIONS",
            "level4": "C09BA",
            "level4_description": "ACE inhibitors and diuretics",
            "level5": "C09BA12",
            "who_name": "delapril and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09B",
            "level3_description": "ACE INHIBITORS, COMBINATIONS",
            "level4": "C09BA",
            "level4_description": "ACE inhibitors and diuretics",
            "level5": "C09BA13",
            "who_name": "moexipril and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09B",
            "level3_description": "ACE INHIBITORS, COMBINATIONS",
            "level4": "C09BA",
            "level4_description": "ACE inhibitors and diuretics",
            "level5": "C09BA15",
            "who_name": "zofenopril and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09B",
            "level3_description": "ACE INHIBITORS, COMBINATIONS",
            "level4": "C09BB",
            "level4_description": "ACE inhibitors and calcium channel blockers",
            "level5": "C09BB02",
            "who_name": "enalapril and lercanidipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09B",
            "level3_description": "ACE INHIBITORS, COMBINATIONS",
            "level4": "C09BB",
            "level4_description": "ACE inhibitors and calcium channel blockers",
            "level5": "C09BB03",
            "who_name": "lisinopril and amlodipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09B",
            "level3_description": "ACE INHIBITORS, COMBINATIONS",
            "level4": "C09BB",
            "level4_description": "ACE inhibitors and calcium channel blockers",
            "level5": "C09BB04",
            "who_name": "perindopril and amlodipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09B",
            "level3_description": "ACE INHIBITORS, COMBINATIONS",
            "level4": "C09BB",
            "level4_description": "ACE inhibitors and calcium channel blockers",
            "level5": "C09BB05",
            "who_name": "ramipril and felodipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09B",
            "level3_description": "ACE INHIBITORS, COMBINATIONS",
            "level4": "C09BB",
            "level4_description": "ACE inhibitors and calcium channel blockers",
            "level5": "C09BB06",
            "who_name": "enalapril and nitrendipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09B",
            "level3_description": "ACE INHIBITORS, COMBINATIONS",
            "level4": "C09BB",
            "level4_description": "ACE inhibitors and calcium channel blockers",
            "level5": "C09BB07",
            "who_name": "ramipril and amlodipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09B",
            "level3_description": "ACE INHIBITORS, COMBINATIONS",
            "level4": "C09BB",
            "level4_description": "ACE inhibitors and calcium channel blockers",
            "level5": "C09BB10",
            "who_name": "trandolapril and verapamil"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09B",
            "level3_description": "ACE INHIBITORS, COMBINATIONS",
            "level4": "C09BB",
            "level4_description": "ACE inhibitors and calcium channel blockers",
            "level5": "C09BB12",
            "who_name": "delapril and manidipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09B",
            "level3_description": "ACE INHIBITORS, COMBINATIONS",
            "level4": "C09BX",
            "level4_description": "ACE inhibitors, other combinations",
            "level5": "C09BX01",
            "who_name": "perindopril, amlodipine and indapamide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09B",
            "level3_description": "ACE INHIBITORS, COMBINATIONS",
            "level4": "C09BX",
            "level4_description": "ACE inhibitors, other combinations",
            "level5": "C09BX02",
            "who_name": "perindopril and bisoprolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09B",
            "level3_description": "ACE INHIBITORS, COMBINATIONS",
            "level4": "C09BX",
            "level4_description": "ACE inhibitors, other combinations",
            "level5": "C09BX03",
            "who_name": "ramipril, amlodipine and hydrochlorothiazide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09B",
            "level3_description": "ACE INHIBITORS, COMBINATIONS",
            "level4": "C09BX",
            "level4_description": "ACE inhibitors, other combinations",
            "level5": "C09BX04",
            "who_name": "perindopril, bisoprolol and amlodipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09B",
            "level3_description": "ACE INHIBITORS, COMBINATIONS",
            "level4": "C09BX",
            "level4_description": "ACE inhibitors, other combinations",
            "level5": "C09BX05",
            "who_name": "ramipril and bisoprolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09C",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN",
            "level4": "C09CA",
            "level4_description": "Angiotensin II receptor blockers (ARBs), plain",
            "level5": "C09CA01",
            "who_name": "losartan"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09C",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN",
            "level4": "C09CA",
            "level4_description": "Angiotensin II receptor blockers (ARBs), plain",
            "level5": "C09CA02",
            "who_name": "eprosartan"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09C",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN",
            "level4": "C09CA",
            "level4_description": "Angiotensin II receptor blockers (ARBs), plain",
            "level5": "C09CA03",
            "who_name": "valsartan"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09C",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN",
            "level4": "C09CA",
            "level4_description": "Angiotensin II receptor blockers (ARBs), plain",
            "level5": "C09CA04",
            "who_name": "irbesartan"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09C",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN",
            "level4": "C09CA",
            "level4_description": "Angiotensin II receptor blockers (ARBs), plain",
            "level5": "C09CA05",
            "who_name": "tasosartan"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09C",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN",
            "level4": "C09CA",
            "level4_description": "Angiotensin II receptor blockers (ARBs), plain",
            "level5": "C09CA06",
            "who_name": "candesartan"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09C",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN",
            "level4": "C09CA",
            "level4_description": "Angiotensin II receptor blockers (ARBs), plain",
            "level5": "C09CA07",
            "who_name": "telmisartan"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09C",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN",
            "level4": "C09CA",
            "level4_description": "Angiotensin II receptor blockers (ARBs), plain",
            "level5": "C09CA08",
            "who_name": "olmesartan medoxomil"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09C",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN",
            "level4": "C09CA",
            "level4_description": "Angiotensin II receptor blockers (ARBs), plain",
            "level5": "C09CA09",
            "who_name": "azilsartan medoxomil"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09C",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN",
            "level4": "C09CA",
            "level4_description": "Angiotensin II receptor blockers (ARBs), plain",
            "level5": "C09CA10",
            "who_name": "fimasartan"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09D",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",
            "level4": "C09DA",
            "level4_description": "Angiotensin II receptor blockers (ARBs) and diuretics",
            "level5": "C09DA01",
            "who_name": "losartan and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09D",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",
            "level4": "C09DA",
            "level4_description": "Angiotensin II receptor blockers (ARBs) and diuretics",
            "level5": "C09DA02",
            "who_name": "eprosartan and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09D",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",
            "level4": "C09DA",
            "level4_description": "Angiotensin II receptor blockers (ARBs) and diuretics",
            "level5": "C09DA03",
            "who_name": "valsartan and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09D",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",
            "level4": "C09DA",
            "level4_description": "Angiotensin II receptor blockers (ARBs) and diuretics",
            "level5": "C09DA04",
            "who_name": "irbesartan and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09D",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",
            "level4": "C09DA",
            "level4_description": "Angiotensin II receptor blockers (ARBs) and diuretics",
            "level5": "C09DA06",
            "who_name": "candesartan and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09D",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",
            "level4": "C09DA",
            "level4_description": "Angiotensin II receptor blockers (ARBs) and diuretics",
            "level5": "C09DA07",
            "who_name": "telmisartan and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09D",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",
            "level4": "C09DA",
            "level4_description": "Angiotensin II receptor blockers (ARBs) and diuretics",
            "level5": "C09DA08",
            "who_name": "olmesartan medoxomil and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09D",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",
            "level4": "C09DA",
            "level4_description": "Angiotensin II receptor blockers (ARBs) and diuretics",
            "level5": "C09DA09",
            "who_name": "azilsartan medoxomil and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09D",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",
            "level4": "C09DA",
            "level4_description": "Angiotensin II receptor blockers (ARBs) and diuretics",
            "level5": "C09DA10",
            "who_name": "fimasartan and diuretics"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09D",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",
            "level4": "C09DB",
            "level4_description": "Angiotensin II receptor blockers (ARBs) and calcium channel blockers",
            "level5": "C09DB01",
            "who_name": "valsartan and amlodipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09D",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",
            "level4": "C09DB",
            "level4_description": "Angiotensin II receptor blockers (ARBs) and calcium channel blockers",
            "level5": "C09DB02",
            "who_name": "olmesartan medoxomil and amlodipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09D",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",
            "level4": "C09DB",
            "level4_description": "Angiotensin II receptor blockers (ARBs) and calcium channel blockers",
            "level5": "C09DB04",
            "who_name": "telmisartan and amlodipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09D",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",
            "level4": "C09DB",
            "level4_description": "Angiotensin II receptor blockers (ARBs) and calcium channel blockers",
            "level5": "C09DB05",
            "who_name": "irbesartan and amlodipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09D",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",
            "level4": "C09DB",
            "level4_description": "Angiotensin II receptor blockers (ARBs) and calcium channel blockers",
            "level5": "C09DB06",
            "who_name": "losartan and amlodipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09D",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",
            "level4": "C09DB",
            "level4_description": "Angiotensin II receptor blockers (ARBs) and calcium channel blockers",
            "level5": "C09DB07",
            "who_name": "candesartan and amlodipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09D",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",
            "level4": "C09DB",
            "level4_description": "Angiotensin II receptor blockers (ARBs) and calcium channel blockers",
            "level5": "C09DB08",
            "who_name": "valsartan and lercanidipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09D",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",
            "level4": "C09DB",
            "level4_description": "Angiotensin II receptor blockers (ARBs) and calcium channel blockers",
            "level5": "C09DB09",
            "who_name": "fimasartan and amlodipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09D",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",
            "level4": "C09DX",
            "level4_description": "Angiotensin II receptor blockers (ARBs), other combinations",
            "level5": "C09DX01",
            "who_name": "valsartan, amlodipine and hydrochlorothiazide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09D",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",
            "level4": "C09DX",
            "level4_description": "Angiotensin II receptor blockers (ARBs), other combinations",
            "level5": "C09DX02",
            "who_name": "valsartan and aliskiren"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09D",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",
            "level4": "C09DX",
            "level4_description": "Angiotensin II receptor blockers (ARBs), other combinations",
            "level5": "C09DX03",
            "who_name": "olmesartan medoxomil, amlodipine and hydrochlorothiazide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09D",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",
            "level4": "C09DX",
            "level4_description": "Angiotensin II receptor blockers (ARBs), other combinations",
            "level5": "C09DX04",
            "who_name": "valsartan and sacubitril"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09D",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",
            "level4": "C09DX",
            "level4_description": "Angiotensin II receptor blockers (ARBs), other combinations",
            "level5": "C09DX05",
            "who_name": "valsartan and nebivolol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09D",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",
            "level4": "C09DX",
            "level4_description": "Angiotensin II receptor blockers (ARBs), other combinations",
            "level5": "C09DX06",
            "who_name": "candesartan, amlodipine and hydrochlorothiazide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09D",
            "level3_description": "ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",
            "level4": "C09DX",
            "level4_description": "Angiotensin II receptor blockers (ARBs), other combinations",
            "level5": "C09DX07",
            "who_name": "irbesartan, amlodipine and hydrochlorothiazide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09X",
            "level3_description": "OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level4": "C09XA",
            "level4_description": "Renin-inhibitors",
            "level5": "C09XA01",
            "who_name": "remikiren"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09X",
            "level3_description": "OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level4": "C09XA",
            "level4_description": "Renin-inhibitors",
            "level5": "C09XA02",
            "who_name": "aliskiren"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09X",
            "level3_description": "OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level4": "C09XA",
            "level4_description": "Renin-inhibitors",
            "level5": "C09XA52",
            "who_name": "aliskiren and hydrochlorothiazide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09X",
            "level3_description": "OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level4": "C09XA",
            "level4_description": "Renin-inhibitors",
            "level5": "C09XA53",
            "who_name": "aliskiren and amlodipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C09",
            "level2_description": "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level3": "C09X",
            "level3_description": "OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",
            "level4": "C09XA",
            "level4_description": "Renin-inhibitors",
            "level5": "C09XA54",
            "who_name": "aliskiren, amlodipine and hydrochlorothiazide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AA",
            "level4_description": "HMG CoA reductase inhibitors",
            "level5": "C10AA01",
            "who_name": "simvastatin"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AA",
            "level4_description": "HMG CoA reductase inhibitors",
            "level5": "C10AA02",
            "who_name": "lovastatin"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AA",
            "level4_description": "HMG CoA reductase inhibitors",
            "level5": "C10AA03",
            "who_name": "pravastatin"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AA",
            "level4_description": "HMG CoA reductase inhibitors",
            "level5": "C10AA04",
            "who_name": "fluvastatin"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AA",
            "level4_description": "HMG CoA reductase inhibitors",
            "level5": "C10AA05",
            "who_name": "atorvastatin"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AA",
            "level4_description": "HMG CoA reductase inhibitors",
            "level5": "C10AA06",
            "who_name": "cerivastatin"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AA",
            "level4_description": "HMG CoA reductase inhibitors",
            "level5": "C10AA07",
            "who_name": "rosuvastatin"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AA",
            "level4_description": "HMG CoA reductase inhibitors",
            "level5": "C10AA08",
            "who_name": "pitavastatin"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AB",
            "level4_description": "Fibrates",
            "level5": "C10AB01",
            "who_name": "clofibrate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AB",
            "level4_description": "Fibrates",
            "level5": "C10AB02",
            "who_name": "bezafibrate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AB",
            "level4_description": "Fibrates",
            "level5": "C10AB03",
            "who_name": "aluminium clofibrate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AB",
            "level4_description": "Fibrates",
            "level5": "C10AB04",
            "who_name": "gemfibrozil"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AB",
            "level4_description": "Fibrates",
            "level5": "C10AB05",
            "who_name": "fenofibrate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AB",
            "level4_description": "Fibrates",
            "level5": "C10AB06",
            "who_name": "simfibrate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AB",
            "level4_description": "Fibrates",
            "level5": "C10AB07",
            "who_name": "ronifibrate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AB",
            "level4_description": "Fibrates",
            "level5": "C10AB08",
            "who_name": "ciprofibrate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AB",
            "level4_description": "Fibrates",
            "level5": "C10AB09",
            "who_name": "etofibrate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AB",
            "level4_description": "Fibrates",
            "level5": "C10AB10",
            "who_name": "clofibride"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AB",
            "level4_description": "Fibrates",
            "level5": "C10AB11",
            "who_name": "choline fenofibrate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AC",
            "level4_description": "Bile acid sequestrants",
            "level5": "C10AC01",
            "who_name": "colestyramine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AC",
            "level4_description": "Bile acid sequestrants",
            "level5": "C10AC02",
            "who_name": "colestipol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AC",
            "level4_description": "Bile acid sequestrants",
            "level5": "C10AC03",
            "who_name": "colextran"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AC",
            "level4_description": "Bile acid sequestrants",
            "level5": "C10AC04",
            "who_name": "colesevelam"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AD",
            "level4_description": "Nicotinic acid and derivatives",
            "level5": "C10AD01",
            "who_name": "niceritrol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AD",
            "level4_description": "Nicotinic acid and derivatives",
            "level5": "C10AD02",
            "who_name": "nicotinic acid"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AD",
            "level4_description": "Nicotinic acid and derivatives",
            "level5": "C10AD03",
            "who_name": "nicofuranose"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AD",
            "level4_description": "Nicotinic acid and derivatives",
            "level5": "C10AD04",
            "who_name": "aluminium nicotinate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AD",
            "level4_description": "Nicotinic acid and derivatives",
            "level5": "C10AD05",
            "who_name": "nicotinyl alcohol (pyridylcarbinol)"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AD",
            "level4_description": "Nicotinic acid and derivatives",
            "level5": "C10AD06",
            "who_name": "acipimox"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AD",
            "level4_description": "Nicotinic acid and derivatives",
            "level5": "C10AD52",
            "who_name": "nicotinic acid, combinations"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AX",
            "level4_description": "Other lipid modifying agents",
            "level5": "C10AX01",
            "who_name": "dextrothyroxine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AX",
            "level4_description": "Other lipid modifying agents",
            "level5": "C10AX02",
            "who_name": "probucol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AX",
            "level4_description": "Other lipid modifying agents",
            "level5": "C10AX03",
            "who_name": "tiadenol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AX",
            "level4_description": "Other lipid modifying agents",
            "level5": "C10AX05",
            "who_name": "meglutol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AX",
            "level4_description": "Other lipid modifying agents",
            "level5": "C10AX06",
            "who_name": "omega-3-triglycerides incl. other esters and acids"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AX",
            "level4_description": "Other lipid modifying agents",
            "level5": "C10AX07",
            "who_name": "magnesium pyridoxal 5-phosphate glutamate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AX",
            "level4_description": "Other lipid modifying agents",
            "level5": "C10AX08",
            "who_name": "policosanol"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AX",
            "level4_description": "Other lipid modifying agents",
            "level5": "C10AX09",
            "who_name": "ezetimibe"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AX",
            "level4_description": "Other lipid modifying agents",
            "level5": "C10AX10",
            "who_name": "alipogene tiparvovec"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AX",
            "level4_description": "Other lipid modifying agents",
            "level5": "C10AX11",
            "who_name": "mipomersen"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AX",
            "level4_description": "Other lipid modifying agents",
            "level5": "C10AX12",
            "who_name": "lomitapide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AX",
            "level4_description": "Other lipid modifying agents",
            "level5": "C10AX13",
            "who_name": "evolocumab"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AX",
            "level4_description": "Other lipid modifying agents",
            "level5": "C10AX14",
            "who_name": "alirocumab"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AX",
            "level4_description": "Other lipid modifying agents",
            "level5": "C10AX15",
            "who_name": "bempedoic acid"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AX",
            "level4_description": "Other lipid modifying agents",
            "level5": "C10AX16",
            "who_name": "inclisiran"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AX",
            "level4_description": "Other lipid modifying agents",
            "level5": "C10AX17",
            "who_name": "evinacumab"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10A",
            "level3_description": "LIPID MODIFYING AGENTS, PLAIN",
            "level4": "C10AX",
            "level4_description": "Other lipid modifying agents",
            "level5": "C10AX18",
            "who_name": "volanesorsen"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BA",
            "level4_description": "Combinations of various lipid modifying agents",
            "level5": "C10BA01",
            "who_name": "lovastatin and nicotinic acid"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BA",
            "level4_description": "Combinations of various lipid modifying agents",
            "level5": "C10BA02",
            "who_name": "simvastatin and ezetimibe"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BA",
            "level4_description": "Combinations of various lipid modifying agents",
            "level5": "C10BA03",
            "who_name": "pravastatin and fenofibrate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BA",
            "level4_description": "Combinations of various lipid modifying agents",
            "level5": "C10BA04",
            "who_name": "simvastatin and fenofibrate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BA",
            "level4_description": "Combinations of various lipid modifying agents",
            "level5": "C10BA05",
            "who_name": "atorvastatin and ezetimibe"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BA",
            "level4_description": "Combinations of various lipid modifying agents",
            "level5": "C10BA06",
            "who_name": "rosuvastatin and ezetimibe"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BA",
            "level4_description": "Combinations of various lipid modifying agents",
            "level5": "C10BA07",
            "who_name": "rosuvastatin and omega-3 fatty acids"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BA",
            "level4_description": "Combinations of various lipid modifying agents",
            "level5": "C10BA08",
            "who_name": "atorvastatin and omega-3 fatty acids"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BA",
            "level4_description": "Combinations of various lipid modifying agents",
            "level5": "C10BA09",
            "who_name": "rosuvastatin and fenofibrate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BA",
            "level4_description": "Combinations of various lipid modifying agents",
            "level5": "C10BA10",
            "who_name": "bempedoic acid and ezetimibe"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BA",
            "level4_description": "Combinations of various lipid modifying agents",
            "level5": "C10BA11",
            "who_name": "pravastatin and ezetimibe"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BA",
            "level4_description": "Combinations of various lipid modifying agents",
            "level5": "C10BA12",
            "who_name": "pravastatin, ezetimibe and fenofibrate"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BX",
            "level4_description": "Lipid modifying agents in combination with other drugs",
            "level5": "C10BX01",
            "who_name": "simvastatin and acetylsalicylic acid"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BX",
            "level4_description": "Lipid modifying agents in combination with other drugs",
            "level5": "C10BX02",
            "who_name": "pravastatin and acetylsalicylic acid"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BX",
            "level4_description": "Lipid modifying agents in combination with other drugs",
            "level5": "C10BX03",
            "who_name": "atorvastatin and amlodipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BX",
            "level4_description": "Lipid modifying agents in combination with other drugs",
            "level5": "C10BX04",
            "who_name": "simvastatin, acetylsalicylic acid and ramipril"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BX",
            "level4_description": "Lipid modifying agents in combination with other drugs",
            "level5": "C10BX05",
            "who_name": "rosuvastatin and acetylsalicylic acid"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BX",
            "level4_description": "Lipid modifying agents in combination with other drugs",
            "level5": "C10BX06",
            "who_name": "atorvastatin, acetylsalicylic acid and ramipril"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BX",
            "level4_description": "Lipid modifying agents in combination with other drugs",
            "level5": "C10BX07",
            "who_name": "rosuvastatin, amlodipine and lisinopril"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BX",
            "level4_description": "Lipid modifying agents in combination with other drugs",
            "level5": "C10BX08",
            "who_name": "atorvastatin and acetylsalicylic acid"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BX",
            "level4_description": "Lipid modifying agents in combination with other drugs",
            "level5": "C10BX09",
            "who_name": "rosuvastatin and amlodipine"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BX",
            "level4_description": "Lipid modifying agents in combination with other drugs",
            "level5": "C10BX10",
            "who_name": "rosuvastatin and valsartan"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BX",
            "level4_description": "Lipid modifying agents in combination with other drugs",
            "level5": "C10BX11",
            "who_name": "atorvastatin, amlodipine and perindopril"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BX",
            "level4_description": "Lipid modifying agents in combination with other drugs",
            "level5": "C10BX12",
            "who_name": "atorvastatin, acetylsalicylic acid and perindopril"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BX",
            "level4_description": "Lipid modifying agents in combination with other drugs",
            "level5": "C10BX13",
            "who_name": "rosuvastatin, perindopril and indapamide"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BX",
            "level4_description": "Lipid modifying agents in combination with other drugs",
            "level5": "C10BX14",
            "who_name": "rosuvastatin, amlodipine and perindopril"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BX",
            "level4_description": "Lipid modifying agents in combination with other drugs",
            "level5": "C10BX15",
            "who_name": "atorvastatin and perindopril"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BX",
            "level4_description": "Lipid modifying agents in combination with other drugs",
            "level5": "C10BX16",
            "who_name": "rosuvastatin and fimasartan"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BX",
            "level4_description": "Lipid modifying agents in combination with other drugs",
            "level5": "C10BX17",
            "who_name": "rosuvastatin and ramipril"
        },
        {
            "level1": "C",
            "level1_description": "CARDIOVASCULAR SYSTEM",
            "level2": "C10",
            "level2_description": "LIPID MODIFYING AGENTS",
            "level3": "C10B",
            "level3_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
            "level4": "C10BX",
            "level4_description": "Lipid modifying agents in combination with other drugs",
            "level5": "C10BX18",
            "who_name": "atorvastatin, amlodipine and ramipril"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AA",
            "level4_description": "Antibiotics",
            "level5": "D01AA01",
            "who_name": "nystatin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AA",
            "level4_description": "Antibiotics",
            "level5": "D01AA02",
            "who_name": "natamycin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AA",
            "level4_description": "Antibiotics",
            "level5": "D01AA03",
            "who_name": "hachimycin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AA",
            "level4_description": "Antibiotics",
            "level5": "D01AA04",
            "who_name": "pecilocin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AA",
            "level4_description": "Antibiotics",
            "level5": "D01AA06",
            "who_name": "mepartricin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AA",
            "level4_description": "Antibiotics",
            "level5": "D01AA07",
            "who_name": "pyrrolnitrin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AA",
            "level4_description": "Antibiotics",
            "level5": "D01AA08",
            "who_name": "griseofulvin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AA",
            "level4_description": "Antibiotics",
            "level5": "D01AA20",
            "who_name": "combinations"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AC",
            "level4_description": "Imidazole and triazole derivatives",
            "level5": "D01AC01",
            "who_name": "clotrimazole"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AC",
            "level4_description": "Imidazole and triazole derivatives",
            "level5": "D01AC02",
            "who_name": "miconazole"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AC",
            "level4_description": "Imidazole and triazole derivatives",
            "level5": "D01AC03",
            "who_name": "econazole"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AC",
            "level4_description": "Imidazole and triazole derivatives",
            "level5": "D01AC04",
            "who_name": "chlormidazole"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AC",
            "level4_description": "Imidazole and triazole derivatives",
            "level5": "D01AC05",
            "who_name": "isoconazole"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AC",
            "level4_description": "Imidazole and triazole derivatives",
            "level5": "D01AC06",
            "who_name": "tiabendazole"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AC",
            "level4_description": "Imidazole and triazole derivatives",
            "level5": "D01AC07",
            "who_name": "tioconazole"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AC",
            "level4_description": "Imidazole and triazole derivatives",
            "level5": "D01AC08",
            "who_name": "ketoconazole"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AC",
            "level4_description": "Imidazole and triazole derivatives",
            "level5": "D01AC09",
            "who_name": "sulconazole"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AC",
            "level4_description": "Imidazole and triazole derivatives",
            "level5": "D01AC10",
            "who_name": "bifonazole"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AC",
            "level4_description": "Imidazole and triazole derivatives",
            "level5": "D01AC11",
            "who_name": "oxiconazole"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AC",
            "level4_description": "Imidazole and triazole derivatives",
            "level5": "D01AC12",
            "who_name": "fenticonazole"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AC",
            "level4_description": "Imidazole and triazole derivatives",
            "level5": "D01AC13",
            "who_name": "omoconazole"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AC",
            "level4_description": "Imidazole and triazole derivatives",
            "level5": "D01AC14",
            "who_name": "sertaconazole"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AC",
            "level4_description": "Imidazole and triazole derivatives",
            "level5": "D01AC15",
            "who_name": "fluconazole"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AC",
            "level4_description": "Imidazole and triazole derivatives",
            "level5": "D01AC16",
            "who_name": "flutrimazole"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AC",
            "level4_description": "Imidazole and triazole derivatives",
            "level5": "D01AC17",
            "who_name": "eberconazole"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AC",
            "level4_description": "Imidazole and triazole derivatives",
            "level5": "D01AC18",
            "who_name": "luliconazole"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AC",
            "level4_description": "Imidazole and triazole derivatives",
            "level5": "D01AC19",
            "who_name": "efinaconazole"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AC",
            "level4_description": "Imidazole and triazole derivatives",
            "level5": "D01AC20",
            "who_name": "imidazoles/triazoles in combination with corticosteroids"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AC",
            "level4_description": "Imidazole and triazole derivatives",
            "level5": "D01AC52",
            "who_name": "miconazole, combinations"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AC",
            "level4_description": "Imidazole and triazole derivatives",
            "level5": "D01AC60",
            "who_name": "bifonazole, combinations"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AE",
            "level4_description": "Other antifungals for topical use",
            "level5": "D01AE01",
            "who_name": "bromochlorosalicylanilide"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AE",
            "level4_description": "Other antifungals for topical use",
            "level5": "D01AE02",
            "who_name": "methylrosaniline"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AE",
            "level4_description": "Other antifungals for topical use",
            "level5": "D01AE03",
            "who_name": "tribromometacresol"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AE",
            "level4_description": "Other antifungals for topical use",
            "level5": "D01AE04",
            "who_name": "undecylenic acid"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AE",
            "level4_description": "Other antifungals for topical use",
            "level5": "D01AE05",
            "who_name": "polynoxylin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AE",
            "level4_description": "Other antifungals for topical use",
            "level5": "D01AE06",
            "who_name": "2-(4-chlorphenoxy)-ethanol"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AE",
            "level4_description": "Other antifungals for topical use",
            "level5": "D01AE07",
            "who_name": "chlorphenesin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AE",
            "level4_description": "Other antifungals for topical use",
            "level5": "D01AE08",
            "who_name": "ticlatone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AE",
            "level4_description": "Other antifungals for topical use",
            "level5": "D01AE09",
            "who_name": "sulbentine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AE",
            "level4_description": "Other antifungals for topical use",
            "level5": "D01AE10",
            "who_name": "ethyl hydroxybenzoate"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AE",
            "level4_description": "Other antifungals for topical use",
            "level5": "D01AE11",
            "who_name": "haloprogin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AE",
            "level4_description": "Other antifungals for topical use",
            "level5": "D01AE12",
            "who_name": "salicylic acid"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AE",
            "level4_description": "Other antifungals for topical use",
            "level5": "D01AE13",
            "who_name": "selenium sulfide"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AE",
            "level4_description": "Other antifungals for topical use",
            "level5": "D01AE14",
            "who_name": "ciclopirox"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AE",
            "level4_description": "Other antifungals for topical use",
            "level5": "D01AE15",
            "who_name": "terbinafine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AE",
            "level4_description": "Other antifungals for topical use",
            "level5": "D01AE16",
            "who_name": "amorolfine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AE",
            "level4_description": "Other antifungals for topical use",
            "level5": "D01AE17",
            "who_name": "dimazole"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AE",
            "level4_description": "Other antifungals for topical use",
            "level5": "D01AE18",
            "who_name": "tolnaftate"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AE",
            "level4_description": "Other antifungals for topical use",
            "level5": "D01AE19",
            "who_name": "tolciclate"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AE",
            "level4_description": "Other antifungals for topical use",
            "level5": "D01AE20",
            "who_name": "combinations"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AE",
            "level4_description": "Other antifungals for topical use",
            "level5": "D01AE21",
            "who_name": "flucytosine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AE",
            "level4_description": "Other antifungals for topical use",
            "level5": "D01AE22",
            "who_name": "naftifine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AE",
            "level4_description": "Other antifungals for topical use",
            "level5": "D01AE23",
            "who_name": "butenafine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AE",
            "level4_description": "Other antifungals for topical use",
            "level5": "D01AE24",
            "who_name": "tavaborole"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01A",
            "level3_description": "ANTIFUNGALS FOR TOPICAL USE",
            "level4": "D01AE",
            "level4_description": "Other antifungals for topical use",
            "level5": "D01AE54",
            "who_name": "undecylenic acid, combinations"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01B",
            "level3_description": "ANTIFUNGALS FOR SYSTEMIC USE",
            "level4": "D01BA",
            "level4_description": "Antifungals for systemic use",
            "level5": "D01BA01",
            "who_name": "griseofulvin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01B",
            "level3_description": "ANTIFUNGALS FOR SYSTEMIC USE",
            "level4": "D01BA",
            "level4_description": "Antifungals for systemic use",
            "level5": "D01BA02",
            "who_name": "terbinafine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D01",
            "level2_description": "ANTIFUNGALS FOR DERMATOLOGICAL USE",
            "level3": "D01B",
            "level3_description": "ANTIFUNGALS FOR SYSTEMIC USE",
            "level4": "D01BA",
            "level4_description": "Antifungals for systemic use",
            "level5": "D01BA03",
            "who_name": "fosravuconazole"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D02",
            "level2_description": "EMOLLIENTS AND PROTECTIVES",
            "level3": "D02A",
            "level3_description": "EMOLLIENTS AND PROTECTIVES",
            "level4": "D02AE",
            "level4_description": "Carbamide products",
            "level5": "D02AE01",
            "who_name": "carbamide"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D02",
            "level2_description": "EMOLLIENTS AND PROTECTIVES",
            "level3": "D02A",
            "level3_description": "EMOLLIENTS AND PROTECTIVES",
            "level4": "D02AE",
            "level4_description": "Carbamide products",
            "level5": "D02AE51",
            "who_name": "carbamide, combinations"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D02",
            "level2_description": "EMOLLIENTS AND PROTECTIVES",
            "level3": "D02B",
            "level3_description": "PROTECTIVES AGAINST UV-RADIATION",
            "level4": "D02BA",
            "level4_description": "Protectives against UV-radiation for topical use",
            "level5": "D02BA01",
            "who_name": "aminobenzoic acid"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D02",
            "level2_description": "EMOLLIENTS AND PROTECTIVES",
            "level3": "D02B",
            "level3_description": "PROTECTIVES AGAINST UV-RADIATION",
            "level4": "D02BA",
            "level4_description": "Protectives against UV-radiation for topical use",
            "level5": "D02BA02",
            "who_name": "octinoxate"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D02",
            "level2_description": "EMOLLIENTS AND PROTECTIVES",
            "level3": "D02B",
            "level3_description": "PROTECTIVES AGAINST UV-RADIATION",
            "level4": "D02BB",
            "level4_description": "Protectives against UV-radiation for systemic use",
            "level5": "D02BB01",
            "who_name": "betacarotene"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D02",
            "level2_description": "EMOLLIENTS AND PROTECTIVES",
            "level3": "D02B",
            "level3_description": "PROTECTIVES AGAINST UV-RADIATION",
            "level4": "D02BB",
            "level4_description": "Protectives against UV-radiation for systemic use",
            "level5": "D02BB02",
            "who_name": "afamelanotide"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D03",
            "level2_description": "PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS",
            "level3": "D03A",
            "level3_description": "CICATRIZANTS",
            "level4": "D03AX",
            "level4_description": "Other cicatrizants",
            "level5": "D03AX01",
            "who_name": "cadexomer iodine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D03",
            "level2_description": "PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS",
            "level3": "D03A",
            "level3_description": "CICATRIZANTS",
            "level4": "D03AX",
            "level4_description": "Other cicatrizants",
            "level5": "D03AX02",
            "who_name": "dextranomer"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D03",
            "level2_description": "PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS",
            "level3": "D03A",
            "level3_description": "CICATRIZANTS",
            "level4": "D03AX",
            "level4_description": "Other cicatrizants",
            "level5": "D03AX03",
            "who_name": "dexpanthenol"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D03",
            "level2_description": "PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS",
            "level3": "D03A",
            "level3_description": "CICATRIZANTS",
            "level4": "D03AX",
            "level4_description": "Other cicatrizants",
            "level5": "D03AX04",
            "who_name": "calcium pantothenate"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D03",
            "level2_description": "PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS",
            "level3": "D03A",
            "level3_description": "CICATRIZANTS",
            "level4": "D03AX",
            "level4_description": "Other cicatrizants",
            "level5": "D03AX05",
            "who_name": "hyaluronic acid"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D03",
            "level2_description": "PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS",
            "level3": "D03A",
            "level3_description": "CICATRIZANTS",
            "level4": "D03AX",
            "level4_description": "Other cicatrizants",
            "level5": "D03AX06",
            "who_name": "becaplermin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D03",
            "level2_description": "PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS",
            "level3": "D03A",
            "level3_description": "CICATRIZANTS",
            "level4": "D03AX",
            "level4_description": "Other cicatrizants",
            "level5": "D03AX09",
            "who_name": "crilanomer"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D03",
            "level2_description": "PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS",
            "level3": "D03A",
            "level3_description": "CICATRIZANTS",
            "level4": "D03AX",
            "level4_description": "Other cicatrizants",
            "level5": "D03AX10",
            "who_name": "enoxolone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D03",
            "level2_description": "PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS",
            "level3": "D03A",
            "level3_description": "CICATRIZANTS",
            "level4": "D03AX",
            "level4_description": "Other cicatrizants",
            "level5": "D03AX11",
            "who_name": "sodium chlorite"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D03",
            "level2_description": "PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS",
            "level3": "D03A",
            "level3_description": "CICATRIZANTS",
            "level4": "D03AX",
            "level4_description": "Other cicatrizants",
            "level5": "D03AX12",
            "who_name": "trolamine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D03",
            "level2_description": "PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS",
            "level3": "D03A",
            "level3_description": "CICATRIZANTS",
            "level4": "D03AX",
            "level4_description": "Other cicatrizants",
            "level5": "D03AX13",
            "who_name": "Betulae cortex"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D03",
            "level2_description": "PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS",
            "level3": "D03A",
            "level3_description": "CICATRIZANTS",
            "level4": "D03AX",
            "level4_description": "Other cicatrizants",
            "level5": "D03AX14",
            "who_name": "Centella asiatica herba"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D03",
            "level2_description": "PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS",
            "level3": "D03A",
            "level3_description": "CICATRIZANTS",
            "level4": "D03AX",
            "level4_description": "Other cicatrizants",
            "level5": "D03AX15",
            "who_name": "trafermin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D03",
            "level2_description": "PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS",
            "level3": "D03B",
            "level3_description": "ENZYMES",
            "level4": "D03BA",
            "level4_description": "Proteolytic enzymes",
            "level5": "D03BA01",
            "who_name": "trypsin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D03",
            "level2_description": "PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS",
            "level3": "D03B",
            "level3_description": "ENZYMES",
            "level4": "D03BA",
            "level4_description": "Proteolytic enzymes",
            "level5": "D03BA02",
            "who_name": "collagenase"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D03",
            "level2_description": "PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS",
            "level3": "D03B",
            "level3_description": "ENZYMES",
            "level4": "D03BA",
            "level4_description": "Proteolytic enzymes",
            "level5": "D03BA03",
            "who_name": "bromelains"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D03",
            "level2_description": "PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS",
            "level3": "D03B",
            "level3_description": "ENZYMES",
            "level4": "D03BA",
            "level4_description": "Proteolytic enzymes",
            "level5": "D03BA52",
            "who_name": "collagenase, combinations"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D04",
            "level2_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level3": "D04A",
            "level3_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level4": "D04AA",
            "level4_description": "Antihistamines for topical use",
            "level5": "D04AA01",
            "who_name": "thonzylamine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D04",
            "level2_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level3": "D04A",
            "level3_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level4": "D04AA",
            "level4_description": "Antihistamines for topical use",
            "level5": "D04AA02",
            "who_name": "mepyramine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D04",
            "level2_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level3": "D04A",
            "level3_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level4": "D04AA",
            "level4_description": "Antihistamines for topical use",
            "level5": "D04AA03",
            "who_name": "thenalidine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D04",
            "level2_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level3": "D04A",
            "level3_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level4": "D04AA",
            "level4_description": "Antihistamines for topical use",
            "level5": "D04AA04",
            "who_name": "tripelennamine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D04",
            "level2_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level3": "D04A",
            "level3_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level4": "D04AA",
            "level4_description": "Antihistamines for topical use",
            "level5": "D04AA09",
            "who_name": "chloropyramine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D04",
            "level2_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level3": "D04A",
            "level3_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level4": "D04AA",
            "level4_description": "Antihistamines for topical use",
            "level5": "D04AA10",
            "who_name": "promethazine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D04",
            "level2_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level3": "D04A",
            "level3_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level4": "D04AA",
            "level4_description": "Antihistamines for topical use",
            "level5": "D04AA12",
            "who_name": "tolpropamine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D04",
            "level2_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level3": "D04A",
            "level3_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level4": "D04AA",
            "level4_description": "Antihistamines for topical use",
            "level5": "D04AA13",
            "who_name": "dimetindene"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D04",
            "level2_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level3": "D04A",
            "level3_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level4": "D04AA",
            "level4_description": "Antihistamines for topical use",
            "level5": "D04AA14",
            "who_name": "clemastine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D04",
            "level2_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level3": "D04A",
            "level3_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level4": "D04AA",
            "level4_description": "Antihistamines for topical use",
            "level5": "D04AA15",
            "who_name": "bamipine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D04",
            "level2_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level3": "D04A",
            "level3_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level4": "D04AA",
            "level4_description": "Antihistamines for topical use",
            "level5": "D04AA16",
            "who_name": "pheniramine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D04",
            "level2_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level3": "D04A",
            "level3_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level4": "D04AA",
            "level4_description": "Antihistamines for topical use",
            "level5": "D04AA22",
            "who_name": "isothipendyl"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D04",
            "level2_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level3": "D04A",
            "level3_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level4": "D04AA",
            "level4_description": "Antihistamines for topical use",
            "level5": "D04AA32",
            "who_name": "diphenhydramine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D04",
            "level2_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level3": "D04A",
            "level3_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level4": "D04AA",
            "level4_description": "Antihistamines for topical use",
            "level5": "D04AA33",
            "who_name": "diphenhydramine methylbromide"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D04",
            "level2_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level3": "D04A",
            "level3_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level4": "D04AA",
            "level4_description": "Antihistamines for topical use",
            "level5": "D04AA34",
            "who_name": "chlorphenoxamine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D04",
            "level2_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level3": "D04A",
            "level3_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level4": "D04AB",
            "level4_description": "Anesthetics for topical use",
            "level5": "D04AB01",
            "who_name": "lidocaine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D04",
            "level2_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level3": "D04A",
            "level3_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level4": "D04AB",
            "level4_description": "Anesthetics for topical use",
            "level5": "D04AB02",
            "who_name": "cinchocaine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D04",
            "level2_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level3": "D04A",
            "level3_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level4": "D04AB",
            "level4_description": "Anesthetics for topical use",
            "level5": "D04AB03",
            "who_name": "oxybuprocaine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D04",
            "level2_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level3": "D04A",
            "level3_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level4": "D04AB",
            "level4_description": "Anesthetics for topical use",
            "level5": "D04AB04",
            "who_name": "benzocaine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D04",
            "level2_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level3": "D04A",
            "level3_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level4": "D04AB",
            "level4_description": "Anesthetics for topical use",
            "level5": "D04AB05",
            "who_name": "quinisocaine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D04",
            "level2_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level3": "D04A",
            "level3_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level4": "D04AB",
            "level4_description": "Anesthetics for topical use",
            "level5": "D04AB06",
            "who_name": "tetracaine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D04",
            "level2_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level3": "D04A",
            "level3_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level4": "D04AB",
            "level4_description": "Anesthetics for topical use",
            "level5": "D04AB07",
            "who_name": "pramocaine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D04",
            "level2_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level3": "D04A",
            "level3_description": "ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",
            "level4": "D04AX",
            "level4_description": "Other antipruritics",
            "level5": "D04AX01",
            "who_name": "doxepin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D05",
            "level2_description": "ANTIPSORIATICS",
            "level3": "D05A",
            "level3_description": "ANTIPSORIATICS FOR TOPICAL USE",
            "level4": "D05AC",
            "level4_description": "Antracen derivatives",
            "level5": "D05AC01",
            "who_name": "dithranol"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D05",
            "level2_description": "ANTIPSORIATICS",
            "level3": "D05A",
            "level3_description": "ANTIPSORIATICS FOR TOPICAL USE",
            "level4": "D05AC",
            "level4_description": "Antracen derivatives",
            "level5": "D05AC51",
            "who_name": "dithranol, combinations"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D05",
            "level2_description": "ANTIPSORIATICS",
            "level3": "D05A",
            "level3_description": "ANTIPSORIATICS FOR TOPICAL USE",
            "level4": "D05AD",
            "level4_description": "Psoralens for topical use",
            "level5": "D05AD01",
            "who_name": "trioxysalen"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D05",
            "level2_description": "ANTIPSORIATICS",
            "level3": "D05A",
            "level3_description": "ANTIPSORIATICS FOR TOPICAL USE",
            "level4": "D05AD",
            "level4_description": "Psoralens for topical use",
            "level5": "D05AD02",
            "who_name": "methoxsalen"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D05",
            "level2_description": "ANTIPSORIATICS",
            "level3": "D05A",
            "level3_description": "ANTIPSORIATICS FOR TOPICAL USE",
            "level4": "D05AX",
            "level4_description": "Other antipsoriatics for topical use",
            "level5": "D05AX01",
            "who_name": "fumaric acid"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D05",
            "level2_description": "ANTIPSORIATICS",
            "level3": "D05A",
            "level3_description": "ANTIPSORIATICS FOR TOPICAL USE",
            "level4": "D05AX",
            "level4_description": "Other antipsoriatics for topical use",
            "level5": "D05AX02",
            "who_name": "calcipotriol"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D05",
            "level2_description": "ANTIPSORIATICS",
            "level3": "D05A",
            "level3_description": "ANTIPSORIATICS FOR TOPICAL USE",
            "level4": "D05AX",
            "level4_description": "Other antipsoriatics for topical use",
            "level5": "D05AX03",
            "who_name": "calcitriol"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D05",
            "level2_description": "ANTIPSORIATICS",
            "level3": "D05A",
            "level3_description": "ANTIPSORIATICS FOR TOPICAL USE",
            "level4": "D05AX",
            "level4_description": "Other antipsoriatics for topical use",
            "level5": "D05AX04",
            "who_name": "tacalcitol"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D05",
            "level2_description": "ANTIPSORIATICS",
            "level3": "D05A",
            "level3_description": "ANTIPSORIATICS FOR TOPICAL USE",
            "level4": "D05AX",
            "level4_description": "Other antipsoriatics for topical use",
            "level5": "D05AX05",
            "who_name": "tazarotene"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D05",
            "level2_description": "ANTIPSORIATICS",
            "level3": "D05A",
            "level3_description": "ANTIPSORIATICS FOR TOPICAL USE",
            "level4": "D05AX",
            "level4_description": "Other antipsoriatics for topical use",
            "level5": "D05AX52",
            "who_name": "calcipotriol, combinations"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D05",
            "level2_description": "ANTIPSORIATICS",
            "level3": "D05A",
            "level3_description": "ANTIPSORIATICS FOR TOPICAL USE",
            "level4": "D05AX",
            "level4_description": "Other antipsoriatics for topical use",
            "level5": "D05AX55",
            "who_name": "tazarotene and ulobetasol"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D05",
            "level2_description": "ANTIPSORIATICS",
            "level3": "D05B",
            "level3_description": "ANTIPSORIATICS FOR SYSTEMIC USE",
            "level4": "D05BA",
            "level4_description": "Psoralens for systemic use",
            "level5": "D05BA01",
            "who_name": "trioxysalen"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D05",
            "level2_description": "ANTIPSORIATICS",
            "level3": "D05B",
            "level3_description": "ANTIPSORIATICS FOR SYSTEMIC USE",
            "level4": "D05BA",
            "level4_description": "Psoralens for systemic use",
            "level5": "D05BA02",
            "who_name": "methoxsalen"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D05",
            "level2_description": "ANTIPSORIATICS",
            "level3": "D05B",
            "level3_description": "ANTIPSORIATICS FOR SYSTEMIC USE",
            "level4": "D05BA",
            "level4_description": "Psoralens for systemic use",
            "level5": "D05BA03",
            "who_name": "bergapten"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D05",
            "level2_description": "ANTIPSORIATICS",
            "level3": "D05B",
            "level3_description": "ANTIPSORIATICS FOR SYSTEMIC USE",
            "level4": "D05BB",
            "level4_description": "Retinoids for treatment of psoriasis",
            "level5": "D05BB01",
            "who_name": "etretinate"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D05",
            "level2_description": "ANTIPSORIATICS",
            "level3": "D05B",
            "level3_description": "ANTIPSORIATICS FOR SYSTEMIC USE",
            "level4": "D05BB",
            "level4_description": "Retinoids for treatment of psoriasis",
            "level5": "D05BB02",
            "who_name": "acitretin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D05",
            "level2_description": "ANTIPSORIATICS",
            "level3": "D05B",
            "level3_description": "ANTIPSORIATICS FOR SYSTEMIC USE",
            "level4": "D05BX",
            "level4_description": "Other antipsoriatics for systemic use",
            "level5": "D05BX51",
            "who_name": "fumaric acid derivatives, combinations"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06A",
            "level3_description": "ANTIBIOTICS FOR TOPICAL USE",
            "level4": "D06AA",
            "level4_description": "Tetracycline and derivatives",
            "level5": "D06AA01",
            "who_name": "demeclocycline"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06A",
            "level3_description": "ANTIBIOTICS FOR TOPICAL USE",
            "level4": "D06AA",
            "level4_description": "Tetracycline and derivatives",
            "level5": "D06AA02",
            "who_name": "chlortetracycline"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06A",
            "level3_description": "ANTIBIOTICS FOR TOPICAL USE",
            "level4": "D06AA",
            "level4_description": "Tetracycline and derivatives",
            "level5": "D06AA03",
            "who_name": "oxytetracycline"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06A",
            "level3_description": "ANTIBIOTICS FOR TOPICAL USE",
            "level4": "D06AA",
            "level4_description": "Tetracycline and derivatives",
            "level5": "D06AA04",
            "who_name": "tetracycline"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06A",
            "level3_description": "ANTIBIOTICS FOR TOPICAL USE",
            "level4": "D06AX",
            "level4_description": "Other antibiotics for topical use",
            "level5": "D06AX01",
            "who_name": "fusidic acid"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06A",
            "level3_description": "ANTIBIOTICS FOR TOPICAL USE",
            "level4": "D06AX",
            "level4_description": "Other antibiotics for topical use",
            "level5": "D06AX02",
            "who_name": "chloramphenicol"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06A",
            "level3_description": "ANTIBIOTICS FOR TOPICAL USE",
            "level4": "D06AX",
            "level4_description": "Other antibiotics for topical use",
            "level5": "D06AX04",
            "who_name": "neomycin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06A",
            "level3_description": "ANTIBIOTICS FOR TOPICAL USE",
            "level4": "D06AX",
            "level4_description": "Other antibiotics for topical use",
            "level5": "D06AX05",
            "who_name": "bacitracin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06A",
            "level3_description": "ANTIBIOTICS FOR TOPICAL USE",
            "level4": "D06AX",
            "level4_description": "Other antibiotics for topical use",
            "level5": "D06AX07",
            "who_name": "gentamicin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06A",
            "level3_description": "ANTIBIOTICS FOR TOPICAL USE",
            "level4": "D06AX",
            "level4_description": "Other antibiotics for topical use",
            "level5": "D06AX08",
            "who_name": "tyrothricin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06A",
            "level3_description": "ANTIBIOTICS FOR TOPICAL USE",
            "level4": "D06AX",
            "level4_description": "Other antibiotics for topical use",
            "level5": "D06AX09",
            "who_name": "mupirocin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06A",
            "level3_description": "ANTIBIOTICS FOR TOPICAL USE",
            "level4": "D06AX",
            "level4_description": "Other antibiotics for topical use",
            "level5": "D06AX10",
            "who_name": "virginiamycin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06A",
            "level3_description": "ANTIBIOTICS FOR TOPICAL USE",
            "level4": "D06AX",
            "level4_description": "Other antibiotics for topical use",
            "level5": "D06AX11",
            "who_name": "rifaximin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06A",
            "level3_description": "ANTIBIOTICS FOR TOPICAL USE",
            "level4": "D06AX",
            "level4_description": "Other antibiotics for topical use",
            "level5": "D06AX12",
            "who_name": "amikacin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06A",
            "level3_description": "ANTIBIOTICS FOR TOPICAL USE",
            "level4": "D06AX",
            "level4_description": "Other antibiotics for topical use",
            "level5": "D06AX13",
            "who_name": "retapamulin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06A",
            "level3_description": "ANTIBIOTICS FOR TOPICAL USE",
            "level4": "D06AX",
            "level4_description": "Other antibiotics for topical use",
            "level5": "D06AX14",
            "who_name": "ozenoxacin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06A",
            "level3_description": "ANTIBIOTICS FOR TOPICAL USE",
            "level4": "D06AX",
            "level4_description": "Other antibiotics for topical use",
            "level5": "D06AX15",
            "who_name": "rifamycin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06B",
            "level3_description": "CHEMOTHERAPEUTICS FOR TOPICAL USE",
            "level4": "D06BA",
            "level4_description": "Sulfonamides",
            "level5": "D06BA01",
            "who_name": "silver sulfadiazine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06B",
            "level3_description": "CHEMOTHERAPEUTICS FOR TOPICAL USE",
            "level4": "D06BA",
            "level4_description": "Sulfonamides",
            "level5": "D06BA02",
            "who_name": "sulfathiazole"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06B",
            "level3_description": "CHEMOTHERAPEUTICS FOR TOPICAL USE",
            "level4": "D06BA",
            "level4_description": "Sulfonamides",
            "level5": "D06BA03",
            "who_name": "mafenide"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06B",
            "level3_description": "CHEMOTHERAPEUTICS FOR TOPICAL USE",
            "level4": "D06BA",
            "level4_description": "Sulfonamides",
            "level5": "D06BA04",
            "who_name": "sulfamethizole"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06B",
            "level3_description": "CHEMOTHERAPEUTICS FOR TOPICAL USE",
            "level4": "D06BA",
            "level4_description": "Sulfonamides",
            "level5": "D06BA05",
            "who_name": "sulfanilamide"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06B",
            "level3_description": "CHEMOTHERAPEUTICS FOR TOPICAL USE",
            "level4": "D06BA",
            "level4_description": "Sulfonamides",
            "level5": "D06BA06",
            "who_name": "sulfamerazine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06B",
            "level3_description": "CHEMOTHERAPEUTICS FOR TOPICAL USE",
            "level4": "D06BA",
            "level4_description": "Sulfonamides",
            "level5": "D06BA51",
            "who_name": "silver sulfadiazine, combinations"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06B",
            "level3_description": "CHEMOTHERAPEUTICS FOR TOPICAL USE",
            "level4": "D06BB",
            "level4_description": "Antivirals",
            "level5": "D06BB01",
            "who_name": "idoxuridine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06B",
            "level3_description": "CHEMOTHERAPEUTICS FOR TOPICAL USE",
            "level4": "D06BB",
            "level4_description": "Antivirals",
            "level5": "D06BB02",
            "who_name": "tromantadine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06B",
            "level3_description": "CHEMOTHERAPEUTICS FOR TOPICAL USE",
            "level4": "D06BB",
            "level4_description": "Antivirals",
            "level5": "D06BB03",
            "who_name": "aciclovir"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06B",
            "level3_description": "CHEMOTHERAPEUTICS FOR TOPICAL USE",
            "level4": "D06BB",
            "level4_description": "Antivirals",
            "level5": "D06BB04",
            "who_name": "podophyllotoxin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06B",
            "level3_description": "CHEMOTHERAPEUTICS FOR TOPICAL USE",
            "level4": "D06BB",
            "level4_description": "Antivirals",
            "level5": "D06BB05",
            "who_name": "inosine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06B",
            "level3_description": "CHEMOTHERAPEUTICS FOR TOPICAL USE",
            "level4": "D06BB",
            "level4_description": "Antivirals",
            "level5": "D06BB06",
            "who_name": "penciclovir"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06B",
            "level3_description": "CHEMOTHERAPEUTICS FOR TOPICAL USE",
            "level4": "D06BB",
            "level4_description": "Antivirals",
            "level5": "D06BB07",
            "who_name": "lysozyme"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06B",
            "level3_description": "CHEMOTHERAPEUTICS FOR TOPICAL USE",
            "level4": "D06BB",
            "level4_description": "Antivirals",
            "level5": "D06BB08",
            "who_name": "ibacitabine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06B",
            "level3_description": "CHEMOTHERAPEUTICS FOR TOPICAL USE",
            "level4": "D06BB",
            "level4_description": "Antivirals",
            "level5": "D06BB09",
            "who_name": "edoxudine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06B",
            "level3_description": "CHEMOTHERAPEUTICS FOR TOPICAL USE",
            "level4": "D06BB",
            "level4_description": "Antivirals",
            "level5": "D06BB10",
            "who_name": "imiquimod"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06B",
            "level3_description": "CHEMOTHERAPEUTICS FOR TOPICAL USE",
            "level4": "D06BB",
            "level4_description": "Antivirals",
            "level5": "D06BB11",
            "who_name": "docosanol"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06B",
            "level3_description": "CHEMOTHERAPEUTICS FOR TOPICAL USE",
            "level4": "D06BB",
            "level4_description": "Antivirals",
            "level5": "D06BB12",
            "who_name": "sinecatechins"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06B",
            "level3_description": "CHEMOTHERAPEUTICS FOR TOPICAL USE",
            "level4": "D06BB",
            "level4_description": "Antivirals",
            "level5": "D06BB53",
            "who_name": "aciclovir, combinations"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06B",
            "level3_description": "CHEMOTHERAPEUTICS FOR TOPICAL USE",
            "level4": "D06BX",
            "level4_description": "Other chemotherapeutics",
            "level5": "D06BX01",
            "who_name": "metronidazole"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06B",
            "level3_description": "CHEMOTHERAPEUTICS FOR TOPICAL USE",
            "level4": "D06BX",
            "level4_description": "Other chemotherapeutics",
            "level5": "D06BX02",
            "who_name": "ingenol mebutate"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D06",
            "level2_description": "ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE",
            "level3": "D06B",
            "level3_description": "CHEMOTHERAPEUTICS FOR TOPICAL USE",
            "level4": "D06BX",
            "level4_description": "Other chemotherapeutics",
            "level5": "D06BX03",
            "who_name": "tirbanibulin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AA",
            "level4_description": "Corticosteroids, weak (group I)",
            "level5": "D07AA01",
            "who_name": "methylprednisolone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AA",
            "level4_description": "Corticosteroids, weak (group I)",
            "level5": "D07AA02",
            "who_name": "hydrocortisone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AA",
            "level4_description": "Corticosteroids, weak (group I)",
            "level5": "D07AA03",
            "who_name": "prednisolone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AB",
            "level4_description": "Corticosteroids, moderately potent (group II)",
            "level5": "D07AB01",
            "who_name": "clobetasone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AB",
            "level4_description": "Corticosteroids, moderately potent (group II)",
            "level5": "D07AB02",
            "who_name": "hydrocortisone butyrate"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AB",
            "level4_description": "Corticosteroids, moderately potent (group II)",
            "level5": "D07AB03",
            "who_name": "flumetasone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AB",
            "level4_description": "Corticosteroids, moderately potent (group II)",
            "level5": "D07AB04",
            "who_name": "fluocortin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AB",
            "level4_description": "Corticosteroids, moderately potent (group II)",
            "level5": "D07AB05",
            "who_name": "fluperolone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AB",
            "level4_description": "Corticosteroids, moderately potent (group II)",
            "level5": "D07AB06",
            "who_name": "fluorometholone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AB",
            "level4_description": "Corticosteroids, moderately potent (group II)",
            "level5": "D07AB07",
            "who_name": "fluprednidene"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AB",
            "level4_description": "Corticosteroids, moderately potent (group II)",
            "level5": "D07AB08",
            "who_name": "desonide"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AB",
            "level4_description": "Corticosteroids, moderately potent (group II)",
            "level5": "D07AB09",
            "who_name": "triamcinolone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AB",
            "level4_description": "Corticosteroids, moderately potent (group II)",
            "level5": "D07AB10",
            "who_name": "alclometasone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AB",
            "level4_description": "Corticosteroids, moderately potent (group II)",
            "level5": "D07AB11",
            "who_name": "hydrocortisone buteprate"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AB",
            "level4_description": "Corticosteroids, moderately potent (group II)",
            "level5": "D07AB19",
            "who_name": "dexamethasone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AB",
            "level4_description": "Corticosteroids, moderately potent (group II)",
            "level5": "D07AB21",
            "who_name": "clocortolone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AB",
            "level4_description": "Corticosteroids, moderately potent (group II)",
            "level5": "D07AB30",
            "who_name": "combinations of corticosteroids"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AC",
            "level4_description": "Corticosteroids, potent (group III)",
            "level5": "D07AC01",
            "who_name": "betamethasone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AC",
            "level4_description": "Corticosteroids, potent (group III)",
            "level5": "D07AC02",
            "who_name": "fluclorolone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AC",
            "level4_description": "Corticosteroids, potent (group III)",
            "level5": "D07AC03",
            "who_name": "desoximetasone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AC",
            "level4_description": "Corticosteroids, potent (group III)",
            "level5": "D07AC04",
            "who_name": "fluocinolone acetonide"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AC",
            "level4_description": "Corticosteroids, potent (group III)",
            "level5": "D07AC05",
            "who_name": "fluocortolone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AC",
            "level4_description": "Corticosteroids, potent (group III)",
            "level5": "D07AC06",
            "who_name": "diflucortolone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AC",
            "level4_description": "Corticosteroids, potent (group III)",
            "level5": "D07AC07",
            "who_name": "fludroxycortide"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AC",
            "level4_description": "Corticosteroids, potent (group III)",
            "level5": "D07AC08",
            "who_name": "fluocinonide"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AC",
            "level4_description": "Corticosteroids, potent (group III)",
            "level5": "D07AC09",
            "who_name": "budesonide"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AC",
            "level4_description": "Corticosteroids, potent (group III)",
            "level5": "D07AC10",
            "who_name": "diflorasone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AC",
            "level4_description": "Corticosteroids, potent (group III)",
            "level5": "D07AC11",
            "who_name": "amcinonide"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AC",
            "level4_description": "Corticosteroids, potent (group III)",
            "level5": "D07AC12",
            "who_name": "halometasone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AC",
            "level4_description": "Corticosteroids, potent (group III)",
            "level5": "D07AC13",
            "who_name": "mometasone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AC",
            "level4_description": "Corticosteroids, potent (group III)",
            "level5": "D07AC14",
            "who_name": "methylprednisolone aceponate"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AC",
            "level4_description": "Corticosteroids, potent (group III)",
            "level5": "D07AC15",
            "who_name": "beclometasone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AC",
            "level4_description": "Corticosteroids, potent (group III)",
            "level5": "D07AC16",
            "who_name": "hydrocortisone aceponate"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AC",
            "level4_description": "Corticosteroids, potent (group III)",
            "level5": "D07AC17",
            "who_name": "fluticasone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AC",
            "level4_description": "Corticosteroids, potent (group III)",
            "level5": "D07AC18",
            "who_name": "prednicarbate"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AC",
            "level4_description": "Corticosteroids, potent (group III)",
            "level5": "D07AC19",
            "who_name": "difluprednate"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AC",
            "level4_description": "Corticosteroids, potent (group III)",
            "level5": "D07AC21",
            "who_name": "ulobetasol"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AD",
            "level4_description": "Corticosteroids, very potent (group IV)",
            "level5": "D07AD01",
            "who_name": "clobetasol"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07A",
            "level3_description": "CORTICOSTEROIDS, PLAIN",
            "level4": "D07AD",
            "level4_description": "Corticosteroids, very potent (group IV)",
            "level5": "D07AD02",
            "who_name": "halcinonide"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07B",
            "level3_description": "CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS",
            "level4": "D07BA",
            "level4_description": "Corticosteroids, weak, combinations with antiseptics",
            "level5": "D07BA01",
            "who_name": "prednisolone and antiseptics"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07B",
            "level3_description": "CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS",
            "level4": "D07BA",
            "level4_description": "Corticosteroids, weak, combinations with antiseptics",
            "level5": "D07BA04",
            "who_name": "hydrocortisone and antiseptics"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07B",
            "level3_description": "CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS",
            "level4": "D07BB",
            "level4_description": "Corticosteroids, moderately potent, combinations with antiseptics",
            "level5": "D07BB01",
            "who_name": "flumetasone and antiseptics"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07B",
            "level3_description": "CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS",
            "level4": "D07BB",
            "level4_description": "Corticosteroids, moderately potent, combinations with antiseptics",
            "level5": "D07BB02",
            "who_name": "desonide and antiseptics"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07B",
            "level3_description": "CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS",
            "level4": "D07BB",
            "level4_description": "Corticosteroids, moderately potent, combinations with antiseptics",
            "level5": "D07BB03",
            "who_name": "triamcinolone and antiseptics"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07B",
            "level3_description": "CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS",
            "level4": "D07BB",
            "level4_description": "Corticosteroids, moderately potent, combinations with antiseptics",
            "level5": "D07BB04",
            "who_name": "hydrocortisone butyrate and antiseptics"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07B",
            "level3_description": "CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS",
            "level4": "D07BC",
            "level4_description": "Corticosteroids, potent, combinations with antiseptics",
            "level5": "D07BC01",
            "who_name": "betamethasone and antiseptics"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07B",
            "level3_description": "CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS",
            "level4": "D07BC",
            "level4_description": "Corticosteroids, potent, combinations with antiseptics",
            "level5": "D07BC02",
            "who_name": "fluocinolone acetonide and antiseptics"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07B",
            "level3_description": "CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS",
            "level4": "D07BC",
            "level4_description": "Corticosteroids, potent, combinations with antiseptics",
            "level5": "D07BC03",
            "who_name": "fluocortolone and antiseptics"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07B",
            "level3_description": "CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS",
            "level4": "D07BC",
            "level4_description": "Corticosteroids, potent, combinations with antiseptics",
            "level5": "D07BC04",
            "who_name": "diflucortolone and antiseptics"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07C",
            "level3_description": "CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS",
            "level4": "D07CA",
            "level4_description": "Corticosteroids, weak, combinations with antibiotics",
            "level5": "D07CA01",
            "who_name": "hydrocortisone and antibiotics"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07C",
            "level3_description": "CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS",
            "level4": "D07CA",
            "level4_description": "Corticosteroids, weak, combinations with antibiotics",
            "level5": "D07CA02",
            "who_name": "methylprednisolone and antibiotics"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07C",
            "level3_description": "CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS",
            "level4": "D07CA",
            "level4_description": "Corticosteroids, weak, combinations with antibiotics",
            "level5": "D07CA03",
            "who_name": "prednisolone and antibiotics"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07C",
            "level3_description": "CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS",
            "level4": "D07CB",
            "level4_description": "Corticosteroids, moderately potent, combinations with antibiotics",
            "level5": "D07CB01",
            "who_name": "triamcinolone and antibiotics"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07C",
            "level3_description": "CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS",
            "level4": "D07CB",
            "level4_description": "Corticosteroids, moderately potent, combinations with antibiotics",
            "level5": "D07CB02",
            "who_name": "fluprednidene and antibiotics"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07C",
            "level3_description": "CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS",
            "level4": "D07CB",
            "level4_description": "Corticosteroids, moderately potent, combinations with antibiotics",
            "level5": "D07CB03",
            "who_name": "fluorometholone and antibiotics"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07C",
            "level3_description": "CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS",
            "level4": "D07CB",
            "level4_description": "Corticosteroids, moderately potent, combinations with antibiotics",
            "level5": "D07CB04",
            "who_name": "dexamethasone and antibiotics"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07C",
            "level3_description": "CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS",
            "level4": "D07CB",
            "level4_description": "Corticosteroids, moderately potent, combinations with antibiotics",
            "level5": "D07CB05",
            "who_name": "flumetasone and antibiotics"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07C",
            "level3_description": "CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS",
            "level4": "D07CC",
            "level4_description": "Corticosteroids, potent, combinations with antibiotics",
            "level5": "D07CC01",
            "who_name": "betamethasone and antibiotics"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07C",
            "level3_description": "CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS",
            "level4": "D07CC",
            "level4_description": "Corticosteroids, potent, combinations with antibiotics",
            "level5": "D07CC02",
            "who_name": "fluocinolone acetonide and antibiotics"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07C",
            "level3_description": "CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS",
            "level4": "D07CC",
            "level4_description": "Corticosteroids, potent, combinations with antibiotics",
            "level5": "D07CC03",
            "who_name": "fludroxycortide and antibiotics"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07C",
            "level3_description": "CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS",
            "level4": "D07CC",
            "level4_description": "Corticosteroids, potent, combinations with antibiotics",
            "level5": "D07CC04",
            "who_name": "beclometasone and antibiotics"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07C",
            "level3_description": "CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS",
            "level4": "D07CC",
            "level4_description": "Corticosteroids, potent, combinations with antibiotics",
            "level5": "D07CC05",
            "who_name": "fluocinonide and antibiotics"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07C",
            "level3_description": "CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS",
            "level4": "D07CC",
            "level4_description": "Corticosteroids, potent, combinations with antibiotics",
            "level5": "D07CC06",
            "who_name": "fluocortolone and antibiotics"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07C",
            "level3_description": "CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS",
            "level4": "D07CD",
            "level4_description": "Corticosteroids, very potent, combinations with antibiotics",
            "level5": "D07CD01",
            "who_name": "clobetasol and antibiotics"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07X",
            "level3_description": "CORTICOSTEROIDS, OTHER COMBINATIONS",
            "level4": "D07XA",
            "level4_description": "Corticosteroids, weak, other combinations",
            "level5": "D07XA01",
            "who_name": "hydrocortisone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07X",
            "level3_description": "CORTICOSTEROIDS, OTHER COMBINATIONS",
            "level4": "D07XA",
            "level4_description": "Corticosteroids, weak, other combinations",
            "level5": "D07XA02",
            "who_name": "prednisolone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07X",
            "level3_description": "CORTICOSTEROIDS, OTHER COMBINATIONS",
            "level4": "D07XB",
            "level4_description": "Corticosteroids, moderately potent, other combinations",
            "level5": "D07XB01",
            "who_name": "flumetasone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07X",
            "level3_description": "CORTICOSTEROIDS, OTHER COMBINATIONS",
            "level4": "D07XB",
            "level4_description": "Corticosteroids, moderately potent, other combinations",
            "level5": "D07XB02",
            "who_name": "triamcinolone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07X",
            "level3_description": "CORTICOSTEROIDS, OTHER COMBINATIONS",
            "level4": "D07XB",
            "level4_description": "Corticosteroids, moderately potent, other combinations",
            "level5": "D07XB03",
            "who_name": "fluprednidene"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07X",
            "level3_description": "CORTICOSTEROIDS, OTHER COMBINATIONS",
            "level4": "D07XB",
            "level4_description": "Corticosteroids, moderately potent, other combinations",
            "level5": "D07XB04",
            "who_name": "fluorometholone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07X",
            "level3_description": "CORTICOSTEROIDS, OTHER COMBINATIONS",
            "level4": "D07XB",
            "level4_description": "Corticosteroids, moderately potent, other combinations",
            "level5": "D07XB05",
            "who_name": "dexamethasone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07X",
            "level3_description": "CORTICOSTEROIDS, OTHER COMBINATIONS",
            "level4": "D07XB",
            "level4_description": "Corticosteroids, moderately potent, other combinations",
            "level5": "D07XB30",
            "who_name": "combinations of corticosteroids"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07X",
            "level3_description": "CORTICOSTEROIDS, OTHER COMBINATIONS",
            "level4": "D07XC",
            "level4_description": "Corticosteroids, potent, other combinations",
            "level5": "D07XC01",
            "who_name": "betamethasone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07X",
            "level3_description": "CORTICOSTEROIDS, OTHER COMBINATIONS",
            "level4": "D07XC",
            "level4_description": "Corticosteroids, potent, other combinations",
            "level5": "D07XC02",
            "who_name": "desoximetasone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07X",
            "level3_description": "CORTICOSTEROIDS, OTHER COMBINATIONS",
            "level4": "D07XC",
            "level4_description": "Corticosteroids, potent, other combinations",
            "level5": "D07XC03",
            "who_name": "mometasone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07X",
            "level3_description": "CORTICOSTEROIDS, OTHER COMBINATIONS",
            "level4": "D07XC",
            "level4_description": "Corticosteroids, potent, other combinations",
            "level5": "D07XC04",
            "who_name": "diflucortolone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D07",
            "level2_description": "CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",
            "level3": "D07X",
            "level3_description": "CORTICOSTEROIDS, OTHER COMBINATIONS",
            "level4": "D07XC",
            "level4_description": "Corticosteroids, potent, other combinations",
            "level5": "D07XC05",
            "who_name": "fluocortolone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AA",
            "level4_description": "Acridine derivatives",
            "level5": "D08AA01",
            "who_name": "ethacridine lactate"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AA",
            "level4_description": "Acridine derivatives",
            "level5": "D08AA02",
            "who_name": "aminoacridine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AA",
            "level4_description": "Acridine derivatives",
            "level5": "D08AA03",
            "who_name": "euflavine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AC",
            "level4_description": "Biguanides and amidines",
            "level5": "D08AC01",
            "who_name": "dibrompropamidine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AC",
            "level4_description": "Biguanides and amidines",
            "level5": "D08AC02",
            "who_name": "chlorhexidine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AC",
            "level4_description": "Biguanides and amidines",
            "level5": "D08AC03",
            "who_name": "propamidine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AC",
            "level4_description": "Biguanides and amidines",
            "level5": "D08AC04",
            "who_name": "hexamidine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AC",
            "level4_description": "Biguanides and amidines",
            "level5": "D08AC05",
            "who_name": "polihexanide"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AC",
            "level4_description": "Biguanides and amidines",
            "level5": "D08AC52",
            "who_name": "chlorhexidine, combinations"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AE",
            "level4_description": "Phenol and derivatives",
            "level5": "D08AE01",
            "who_name": "hexachlorophene"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AE",
            "level4_description": "Phenol and derivatives",
            "level5": "D08AE02",
            "who_name": "policresulen"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AE",
            "level4_description": "Phenol and derivatives",
            "level5": "D08AE03",
            "who_name": "phenol"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AE",
            "level4_description": "Phenol and derivatives",
            "level5": "D08AE04",
            "who_name": "triclosan"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AE",
            "level4_description": "Phenol and derivatives",
            "level5": "D08AE05",
            "who_name": "chloroxylenol"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AE",
            "level4_description": "Phenol and derivatives",
            "level5": "D08AE06",
            "who_name": "biphenylol"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AF",
            "level4_description": "Nitrofuran derivatives",
            "level5": "D08AF01",
            "who_name": "nitrofural"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AG",
            "level4_description": "Iodine products",
            "level5": "D08AG01",
            "who_name": "iodine/octylphenoxypolyglycolether"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AG",
            "level4_description": "Iodine products",
            "level5": "D08AG02",
            "who_name": "povidone-iodine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AG",
            "level4_description": "Iodine products",
            "level5": "D08AG03",
            "who_name": "iodine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AG",
            "level4_description": "Iodine products",
            "level5": "D08AG04",
            "who_name": "diiodohydroxypropane"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AH",
            "level4_description": "Quinoline derivatives",
            "level5": "D08AH01",
            "who_name": "dequalinium"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AH",
            "level4_description": "Quinoline derivatives",
            "level5": "D08AH02",
            "who_name": "chlorquinaldol"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AH",
            "level4_description": "Quinoline derivatives",
            "level5": "D08AH03",
            "who_name": "oxyquinoline"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AH",
            "level4_description": "Quinoline derivatives",
            "level5": "D08AH30",
            "who_name": "clioquinol"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AJ",
            "level4_description": "Quaternary ammonium compounds",
            "level5": "D08AJ01",
            "who_name": "benzalkonium"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AJ",
            "level4_description": "Quaternary ammonium compounds",
            "level5": "D08AJ02",
            "who_name": "cetrimonium"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AJ",
            "level4_description": "Quaternary ammonium compounds",
            "level5": "D08AJ03",
            "who_name": "cetylpyridinium"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AJ",
            "level4_description": "Quaternary ammonium compounds",
            "level5": "D08AJ04",
            "who_name": "cetrimide"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AJ",
            "level4_description": "Quaternary ammonium compounds",
            "level5": "D08AJ05",
            "who_name": "benzoxonium chloride"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AJ",
            "level4_description": "Quaternary ammonium compounds",
            "level5": "D08AJ06",
            "who_name": "didecyldimethylammonium chloride"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AJ",
            "level4_description": "Quaternary ammonium compounds",
            "level5": "D08AJ08",
            "who_name": "benzethonium chloride"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AJ",
            "level4_description": "Quaternary ammonium compounds",
            "level5": "D08AJ10",
            "who_name": "decamethoxine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AJ",
            "level4_description": "Quaternary ammonium compounds",
            "level5": "D08AJ57",
            "who_name": "octenidine, combinations"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AJ",
            "level4_description": "Quaternary ammonium compounds",
            "level5": "D08AJ58",
            "who_name": "benzethonium chloride, combinations"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AJ",
            "level4_description": "Quaternary ammonium compounds",
            "level5": "D08AJ59",
            "who_name": "dodeclonium bromide, combinations"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AK",
            "level4_description": "Mercurial products",
            "level5": "D08AK01",
            "who_name": "mercuric amidochloride"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AK",
            "level4_description": "Mercurial products",
            "level5": "D08AK02",
            "who_name": "phenylmercuric borate"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AK",
            "level4_description": "Mercurial products",
            "level5": "D08AK03",
            "who_name": "mercuric chloride"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AK",
            "level4_description": "Mercurial products",
            "level5": "D08AK04",
            "who_name": "merbromin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AK",
            "level4_description": "Mercurial products",
            "level5": "D08AK05",
            "who_name": "mercury, metallic"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AK",
            "level4_description": "Mercurial products",
            "level5": "D08AK06",
            "who_name": "thiomersal"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AK",
            "level4_description": "Mercurial products",
            "level5": "D08AK30",
            "who_name": "mercuric iodide"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AL",
            "level4_description": "Silver compounds",
            "level5": "D08AL01",
            "who_name": "silver nitrate"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AL",
            "level4_description": "Silver compounds",
            "level5": "D08AL30",
            "who_name": "silver"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AX",
            "level4_description": "Other antiseptics and disinfectants",
            "level5": "D08AX01",
            "who_name": "hydrogen peroxide"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AX",
            "level4_description": "Other antiseptics and disinfectants",
            "level5": "D08AX02",
            "who_name": "eosin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AX",
            "level4_description": "Other antiseptics and disinfectants",
            "level5": "D08AX03",
            "who_name": "propanol"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AX",
            "level4_description": "Other antiseptics and disinfectants",
            "level5": "D08AX04",
            "who_name": "tosylchloramide sodium"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AX",
            "level4_description": "Other antiseptics and disinfectants",
            "level5": "D08AX05",
            "who_name": "isopropanol"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AX",
            "level4_description": "Other antiseptics and disinfectants",
            "level5": "D08AX06",
            "who_name": "potassium permanganate"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AX",
            "level4_description": "Other antiseptics and disinfectants",
            "level5": "D08AX07",
            "who_name": "sodium hypochlorite"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AX",
            "level4_description": "Other antiseptics and disinfectants",
            "level5": "D08AX08",
            "who_name": "ethanol"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D08",
            "level2_description": "ANTISEPTICS AND DISINFECTANTS",
            "level3": "D08A",
            "level3_description": "ANTISEPTICS AND DISINFECTANTS",
            "level4": "D08AX",
            "level4_description": "Other antiseptics and disinfectants",
            "level5": "D08AX53",
            "who_name": "propanol, combinations"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D09",
            "level2_description": "MEDICATED DRESSINGS",
            "level3": "D09A",
            "level3_description": "MEDICATED DRESSINGS",
            "level4": "D09AA",
            "level4_description": "Medicated dressings with antiinfectives",
            "level5": "D09AA01",
            "who_name": "framycetin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D09",
            "level2_description": "MEDICATED DRESSINGS",
            "level3": "D09A",
            "level3_description": "MEDICATED DRESSINGS",
            "level4": "D09AA",
            "level4_description": "Medicated dressings with antiinfectives",
            "level5": "D09AA02",
            "who_name": "fusidic acid"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D09",
            "level2_description": "MEDICATED DRESSINGS",
            "level3": "D09A",
            "level3_description": "MEDICATED DRESSINGS",
            "level4": "D09AA",
            "level4_description": "Medicated dressings with antiinfectives",
            "level5": "D09AA03",
            "who_name": "nitrofural"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D09",
            "level2_description": "MEDICATED DRESSINGS",
            "level3": "D09A",
            "level3_description": "MEDICATED DRESSINGS",
            "level4": "D09AA",
            "level4_description": "Medicated dressings with antiinfectives",
            "level5": "D09AA04",
            "who_name": "phenylmercuric nitrate"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D09",
            "level2_description": "MEDICATED DRESSINGS",
            "level3": "D09A",
            "level3_description": "MEDICATED DRESSINGS",
            "level4": "D09AA",
            "level4_description": "Medicated dressings with antiinfectives",
            "level5": "D09AA05",
            "who_name": "benzododecinium"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D09",
            "level2_description": "MEDICATED DRESSINGS",
            "level3": "D09A",
            "level3_description": "MEDICATED DRESSINGS",
            "level4": "D09AA",
            "level4_description": "Medicated dressings with antiinfectives",
            "level5": "D09AA06",
            "who_name": "triclosan"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D09",
            "level2_description": "MEDICATED DRESSINGS",
            "level3": "D09A",
            "level3_description": "MEDICATED DRESSINGS",
            "level4": "D09AA",
            "level4_description": "Medicated dressings with antiinfectives",
            "level5": "D09AA07",
            "who_name": "cetylpyridinium"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D09",
            "level2_description": "MEDICATED DRESSINGS",
            "level3": "D09A",
            "level3_description": "MEDICATED DRESSINGS",
            "level4": "D09AA",
            "level4_description": "Medicated dressings with antiinfectives",
            "level5": "D09AA08",
            "who_name": "aluminium chlorohydrate"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D09",
            "level2_description": "MEDICATED DRESSINGS",
            "level3": "D09A",
            "level3_description": "MEDICATED DRESSINGS",
            "level4": "D09AA",
            "level4_description": "Medicated dressings with antiinfectives",
            "level5": "D09AA09",
            "who_name": "povidone-iodine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D09",
            "level2_description": "MEDICATED DRESSINGS",
            "level3": "D09A",
            "level3_description": "MEDICATED DRESSINGS",
            "level4": "D09AA",
            "level4_description": "Medicated dressings with antiinfectives",
            "level5": "D09AA10",
            "who_name": "clioquinol"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D09",
            "level2_description": "MEDICATED DRESSINGS",
            "level3": "D09A",
            "level3_description": "MEDICATED DRESSINGS",
            "level4": "D09AA",
            "level4_description": "Medicated dressings with antiinfectives",
            "level5": "D09AA11",
            "who_name": "benzalkonium"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D09",
            "level2_description": "MEDICATED DRESSINGS",
            "level3": "D09A",
            "level3_description": "MEDICATED DRESSINGS",
            "level4": "D09AA",
            "level4_description": "Medicated dressings with antiinfectives",
            "level5": "D09AA12",
            "who_name": "chlorhexidine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D09",
            "level2_description": "MEDICATED DRESSINGS",
            "level3": "D09A",
            "level3_description": "MEDICATED DRESSINGS",
            "level4": "D09AA",
            "level4_description": "Medicated dressings with antiinfectives",
            "level5": "D09AA13",
            "who_name": "iodoform"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D09",
            "level2_description": "MEDICATED DRESSINGS",
            "level3": "D09A",
            "level3_description": "MEDICATED DRESSINGS",
            "level4": "D09AB",
            "level4_description": "Zinc bandages",
            "level5": "D09AB01",
            "who_name": "zinc bandage without supplements"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D09",
            "level2_description": "MEDICATED DRESSINGS",
            "level3": "D09A",
            "level3_description": "MEDICATED DRESSINGS",
            "level4": "D09AB",
            "level4_description": "Zinc bandages",
            "level5": "D09AB02",
            "who_name": "zinc bandage with supplements"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AA",
            "level4_description": "Corticosteroids, combinations for treatment of acne",
            "level5": "D10AA01",
            "who_name": "fluorometholone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AA",
            "level4_description": "Corticosteroids, combinations for treatment of acne",
            "level5": "D10AA02",
            "who_name": "methylprednisolone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AA",
            "level4_description": "Corticosteroids, combinations for treatment of acne",
            "level5": "D10AA03",
            "who_name": "dexamethasone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AB",
            "level4_description": "Preparations containing sulfur",
            "level5": "D10AB01",
            "who_name": "bithionol"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AB",
            "level4_description": "Preparations containing sulfur",
            "level5": "D10AB02",
            "who_name": "sulfur"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AB",
            "level4_description": "Preparations containing sulfur",
            "level5": "D10AB03",
            "who_name": "tioxolone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AB",
            "level4_description": "Preparations containing sulfur",
            "level5": "D10AB05",
            "who_name": "mesulfen"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AD",
            "level4_description": "Retinoids for topical use in acne",
            "level5": "D10AD01",
            "who_name": "tretinoin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AD",
            "level4_description": "Retinoids for topical use in acne",
            "level5": "D10AD02",
            "who_name": "retinol"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AD",
            "level4_description": "Retinoids for topical use in acne",
            "level5": "D10AD03",
            "who_name": "adapalene"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AD",
            "level4_description": "Retinoids for topical use in acne",
            "level5": "D10AD04",
            "who_name": "isotretinoin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AD",
            "level4_description": "Retinoids for topical use in acne",
            "level5": "D10AD05",
            "who_name": "motretinide"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AD",
            "level4_description": "Retinoids for topical use in acne",
            "level5": "D10AD06",
            "who_name": "trifarotene"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AD",
            "level4_description": "Retinoids for topical use in acne",
            "level5": "D10AD51",
            "who_name": "tretinoin, combinations"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AD",
            "level4_description": "Retinoids for topical use in acne",
            "level5": "D10AD53",
            "who_name": "adapalene, combinations"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AD",
            "level4_description": "Retinoids for topical use in acne",
            "level5": "D10AD54",
            "who_name": "isotretinoin, combinations"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AE",
            "level4_description": "Peroxides",
            "level5": "D10AE01",
            "who_name": "benzoyl peroxide"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AE",
            "level4_description": "Peroxides",
            "level5": "D10AE51",
            "who_name": "benzoyl peroxide, combinations"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AF",
            "level4_description": "Antiinfectives for treatment of acne",
            "level5": "D10AF01",
            "who_name": "clindamycin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AF",
            "level4_description": "Antiinfectives for treatment of acne",
            "level5": "D10AF02",
            "who_name": "erythromycin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AF",
            "level4_description": "Antiinfectives for treatment of acne",
            "level5": "D10AF03",
            "who_name": "chloramphenicol"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AF",
            "level4_description": "Antiinfectives for treatment of acne",
            "level5": "D10AF04",
            "who_name": "meclocycline"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AF",
            "level4_description": "Antiinfectives for treatment of acne",
            "level5": "D10AF05",
            "who_name": "nadifloxacin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AF",
            "level4_description": "Antiinfectives for treatment of acne",
            "level5": "D10AF06",
            "who_name": "sulfacetamide"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AF",
            "level4_description": "Antiinfectives for treatment of acne",
            "level5": "D10AF07",
            "who_name": "minocycline"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AF",
            "level4_description": "Antiinfectives for treatment of acne",
            "level5": "D10AF51",
            "who_name": "clindamycin, combinations"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AF",
            "level4_description": "Antiinfectives for treatment of acne",
            "level5": "D10AF52",
            "who_name": "erythromycin, combinations"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AX",
            "level4_description": "Other anti-acne preparations for topical use",
            "level5": "D10AX01",
            "who_name": "aluminium chloride"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AX",
            "level4_description": "Other anti-acne preparations for topical use",
            "level5": "D10AX02",
            "who_name": "resorcinol"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AX",
            "level4_description": "Other anti-acne preparations for topical use",
            "level5": "D10AX03",
            "who_name": "azelaic acid"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AX",
            "level4_description": "Other anti-acne preparations for topical use",
            "level5": "D10AX04",
            "who_name": "aluminium oxide"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AX",
            "level4_description": "Other anti-acne preparations for topical use",
            "level5": "D10AX05",
            "who_name": "dapsone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AX",
            "level4_description": "Other anti-acne preparations for topical use",
            "level5": "D10AX06",
            "who_name": "clascoterone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10A",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
            "level4": "D10AX",
            "level4_description": "Other anti-acne preparations for topical use",
            "level5": "D10AX30",
            "who_name": "various combinations"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10B",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE",
            "level4": "D10BA",
            "level4_description": "Retinoids for treatment of acne",
            "level5": "D10BA01",
            "who_name": "isotretinoin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D10",
            "level2_description": "ANTI-ACNE PREPARATIONS",
            "level3": "D10B",
            "level3_description": "ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE",
            "level4": "D10BX",
            "level4_description": "Other anti-acne preparations for systemic use",
            "level5": "D10BX01",
            "who_name": "ichtasol"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AA",
            "level4_description": "Antihidrotics",
            "level5": "D11AA01",
            "who_name": "glycopyrronium"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AC",
            "level4_description": "Medicated shampoos",
            "level5": "D11AC01",
            "who_name": "cetrimide"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AC",
            "level4_description": "Medicated shampoos",
            "level5": "D11AC02",
            "who_name": "cadmium compounds"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AC",
            "level4_description": "Medicated shampoos",
            "level5": "D11AC03",
            "who_name": "selenium compounds"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AC",
            "level4_description": "Medicated shampoos",
            "level5": "D11AC06",
            "who_name": "povidone-iodine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AC",
            "level4_description": "Medicated shampoos",
            "level5": "D11AC08",
            "who_name": "sulfur compounds"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AC",
            "level4_description": "Medicated shampoos",
            "level5": "D11AC09",
            "who_name": "xenysalate"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AC",
            "level4_description": "Medicated shampoos",
            "level5": "D11AC30",
            "who_name": "others"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AE",
            "level4_description": "Androgens for topical use",
            "level5": "D11AE01",
            "who_name": "metandienone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AH",
            "level4_description": "Agents for dermatitis, excluding corticosteroids",
            "level5": "D11AH01",
            "who_name": "tacrolimus"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AH",
            "level4_description": "Agents for dermatitis, excluding corticosteroids",
            "level5": "D11AH02",
            "who_name": "pimecrolimus"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AH",
            "level4_description": "Agents for dermatitis, excluding corticosteroids",
            "level5": "D11AH03",
            "who_name": "cromoglicic acid"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AH",
            "level4_description": "Agents for dermatitis, excluding corticosteroids",
            "level5": "D11AH04",
            "who_name": "alitretinoin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AH",
            "level4_description": "Agents for dermatitis, excluding corticosteroids",
            "level5": "D11AH05",
            "who_name": "dupilumab"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AH",
            "level4_description": "Agents for dermatitis, excluding corticosteroids",
            "level5": "D11AH06",
            "who_name": "crisaborole"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AH",
            "level4_description": "Agents for dermatitis, excluding corticosteroids",
            "level5": "D11AH07",
            "who_name": "tralokinumab"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AH",
            "level4_description": "Agents for dermatitis, excluding corticosteroids",
            "level5": "D11AH08",
            "who_name": "abrocitinib"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AX",
            "level4_description": "Other dermatologicals",
            "level5": "D11AX01",
            "who_name": "minoxidil"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AX",
            "level4_description": "Other dermatologicals",
            "level5": "D11AX02",
            "who_name": "gamolenic acid"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AX",
            "level4_description": "Other dermatologicals",
            "level5": "D11AX03",
            "who_name": "calcium gluconate"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AX",
            "level4_description": "Other dermatologicals",
            "level5": "D11AX04",
            "who_name": "lithium succinate"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AX",
            "level4_description": "Other dermatologicals",
            "level5": "D11AX05",
            "who_name": "magnesium sulfate"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AX",
            "level4_description": "Other dermatologicals",
            "level5": "D11AX06",
            "who_name": "mequinol"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AX",
            "level4_description": "Other dermatologicals",
            "level5": "D11AX08",
            "who_name": "tiratricol"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AX",
            "level4_description": "Other dermatologicals",
            "level5": "D11AX09",
            "who_name": "oxaceprol"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AX",
            "level4_description": "Other dermatologicals",
            "level5": "D11AX10",
            "who_name": "finasteride"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AX",
            "level4_description": "Other dermatologicals",
            "level5": "D11AX11",
            "who_name": "hydroquinone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AX",
            "level4_description": "Other dermatologicals",
            "level5": "D11AX12",
            "who_name": "pyrithione zinc"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AX",
            "level4_description": "Other dermatologicals",
            "level5": "D11AX13",
            "who_name": "monobenzone"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AX",
            "level4_description": "Other dermatologicals",
            "level5": "D11AX16",
            "who_name": "eflornithine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AX",
            "level4_description": "Other dermatologicals",
            "level5": "D11AX18",
            "who_name": "diclofenac"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AX",
            "level4_description": "Other dermatologicals",
            "level5": "D11AX21",
            "who_name": "brimonidine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AX",
            "level4_description": "Other dermatologicals",
            "level5": "D11AX22",
            "who_name": "ivermectin"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AX",
            "level4_description": "Other dermatologicals",
            "level5": "D11AX23",
            "who_name": "aminobenzoate potassium"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AX",
            "level4_description": "Other dermatologicals",
            "level5": "D11AX24",
            "who_name": "deoxycholic acid"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AX",
            "level4_description": "Other dermatologicals",
            "level5": "D11AX25",
            "who_name": "hydrogen peroxide"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AX",
            "level4_description": "Other dermatologicals",
            "level5": "D11AX26",
            "who_name": "caffeine"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AX",
            "level4_description": "Other dermatologicals",
            "level5": "D11AX27",
            "who_name": "oxymetazoline"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AX",
            "level4_description": "Other dermatologicals",
            "level5": "D11AX52",
            "who_name": "gamolenic acid, combinations"
        },
        {
            "level1": "D",
            "level1_description": "DERMATOLOGICALS",
            "level2": "D11",
            "level2_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level3": "D11A",
            "level3_description": "OTHER DERMATOLOGICAL PREPARATIONS",
            "level4": "D11AX",
            "level4_description": "Other dermatologicals",
            "level5": "D11AX57",
            "who_name": "collagen, combinations"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AA",
            "level4_description": "Antibiotics",
            "level5": "G01AA01",
            "who_name": "nystatin"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AA",
            "level4_description": "Antibiotics",
            "level5": "G01AA02",
            "who_name": "natamycin"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AA",
            "level4_description": "Antibiotics",
            "level5": "G01AA03",
            "who_name": "amphotericin B"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AA",
            "level4_description": "Antibiotics",
            "level5": "G01AA04",
            "who_name": "candicidin"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AA",
            "level4_description": "Antibiotics",
            "level5": "G01AA05",
            "who_name": "chloramphenicol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AA",
            "level4_description": "Antibiotics",
            "level5": "G01AA06",
            "who_name": "hachimycin"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AA",
            "level4_description": "Antibiotics",
            "level5": "G01AA07",
            "who_name": "oxytetracycline"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AA",
            "level4_description": "Antibiotics",
            "level5": "G01AA08",
            "who_name": "carfecillin"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AA",
            "level4_description": "Antibiotics",
            "level5": "G01AA09",
            "who_name": "mepartricin"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AA",
            "level4_description": "Antibiotics",
            "level5": "G01AA10",
            "who_name": "clindamycin"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AA",
            "level4_description": "Antibiotics",
            "level5": "G01AA11",
            "who_name": "pentamycin"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AA",
            "level4_description": "Antibiotics",
            "level5": "G01AA51",
            "who_name": "nystatin, combinations"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AB",
            "level4_description": "Arsenic compounds",
            "level5": "G01AB01",
            "who_name": "acetarsol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AC",
            "level4_description": "Quinoline derivatives",
            "level5": "G01AC01",
            "who_name": "diiodohydroxyquinoline"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AC",
            "level4_description": "Quinoline derivatives",
            "level5": "G01AC02",
            "who_name": "clioquinol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AC",
            "level4_description": "Quinoline derivatives",
            "level5": "G01AC03",
            "who_name": "chlorquinaldol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AC",
            "level4_description": "Quinoline derivatives",
            "level5": "G01AC05",
            "who_name": "dequalinium"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AC",
            "level4_description": "Quinoline derivatives",
            "level5": "G01AC06",
            "who_name": "broxyquinoline"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AC",
            "level4_description": "Quinoline derivatives",
            "level5": "G01AC30",
            "who_name": "oxyquinoline"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AD",
            "level4_description": "Organic acids",
            "level5": "G01AD01",
            "who_name": "lactic acid"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AD",
            "level4_description": "Organic acids",
            "level5": "G01AD02",
            "who_name": "acetic acid"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AD",
            "level4_description": "Organic acids",
            "level5": "G01AD03",
            "who_name": "ascorbic acid"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AE",
            "level4_description": "Sulfonamides",
            "level5": "G01AE01",
            "who_name": "sulfatolamide"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AE",
            "level4_description": "Sulfonamides",
            "level5": "G01AE10",
            "who_name": "combinations of sulfonamides"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AF",
            "level4_description": "Imidazole derivatives",
            "level5": "G01AF01",
            "who_name": "metronidazole"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AF",
            "level4_description": "Imidazole derivatives",
            "level5": "G01AF02",
            "who_name": "clotrimazole"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AF",
            "level4_description": "Imidazole derivatives",
            "level5": "G01AF04",
            "who_name": "miconazole"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AF",
            "level4_description": "Imidazole derivatives",
            "level5": "G01AF05",
            "who_name": "econazole"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AF",
            "level4_description": "Imidazole derivatives",
            "level5": "G01AF06",
            "who_name": "ornidazole"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AF",
            "level4_description": "Imidazole derivatives",
            "level5": "G01AF07",
            "who_name": "isoconazole"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AF",
            "level4_description": "Imidazole derivatives",
            "level5": "G01AF08",
            "who_name": "tioconazole"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AF",
            "level4_description": "Imidazole derivatives",
            "level5": "G01AF11",
            "who_name": "ketoconazole"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AF",
            "level4_description": "Imidazole derivatives",
            "level5": "G01AF12",
            "who_name": "fenticonazole"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AF",
            "level4_description": "Imidazole derivatives",
            "level5": "G01AF13",
            "who_name": "azanidazole"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AF",
            "level4_description": "Imidazole derivatives",
            "level5": "G01AF14",
            "who_name": "propenidazole"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AF",
            "level4_description": "Imidazole derivatives",
            "level5": "G01AF15",
            "who_name": "butoconazole"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AF",
            "level4_description": "Imidazole derivatives",
            "level5": "G01AF16",
            "who_name": "omoconazole"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AF",
            "level4_description": "Imidazole derivatives",
            "level5": "G01AF17",
            "who_name": "oxiconazole"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AF",
            "level4_description": "Imidazole derivatives",
            "level5": "G01AF18",
            "who_name": "flutrimazole"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AF",
            "level4_description": "Imidazole derivatives",
            "level5": "G01AF19",
            "who_name": "sertaconazole"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AF",
            "level4_description": "Imidazole derivatives",
            "level5": "G01AF20",
            "who_name": "combinations of imidazole derivatives"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AF",
            "level4_description": "Imidazole derivatives",
            "level5": "G01AF55",
            "who_name": "econazole, combinations"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AG",
            "level4_description": "Triazole derivatives",
            "level5": "G01AG02",
            "who_name": "terconazole"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AX",
            "level4_description": "Other antiinfectives and antiseptics",
            "level5": "G01AX01",
            "who_name": "clodantoin"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AX",
            "level4_description": "Other antiinfectives and antiseptics",
            "level5": "G01AX02",
            "who_name": "inosine"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AX",
            "level4_description": "Other antiinfectives and antiseptics",
            "level5": "G01AX03",
            "who_name": "policresulen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AX",
            "level4_description": "Other antiinfectives and antiseptics",
            "level5": "G01AX05",
            "who_name": "nifuratel"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AX",
            "level4_description": "Other antiinfectives and antiseptics",
            "level5": "G01AX06",
            "who_name": "furazolidone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AX",
            "level4_description": "Other antiinfectives and antiseptics",
            "level5": "G01AX09",
            "who_name": "methylrosaniline"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AX",
            "level4_description": "Other antiinfectives and antiseptics",
            "level5": "G01AX11",
            "who_name": "povidone-iodine"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AX",
            "level4_description": "Other antiinfectives and antiseptics",
            "level5": "G01AX12",
            "who_name": "ciclopirox"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AX",
            "level4_description": "Other antiinfectives and antiseptics",
            "level5": "G01AX13",
            "who_name": "protiofate"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AX",
            "level4_description": "Other antiinfectives and antiseptics",
            "level5": "G01AX14",
            "who_name": "lactobacillus"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AX",
            "level4_description": "Other antiinfectives and antiseptics",
            "level5": "G01AX15",
            "who_name": "copper usnate"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AX",
            "level4_description": "Other antiinfectives and antiseptics",
            "level5": "G01AX16",
            "who_name": "hexetidine"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AX",
            "level4_description": "Other antiinfectives and antiseptics",
            "level5": "G01AX17",
            "who_name": "dapivirine"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G01",
            "level2_description": "GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",
            "level3": "G01A",
            "level3_description": "ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",
            "level4": "G01AX",
            "level4_description": "Other antiinfectives and antiseptics",
            "level5": "G01AX66",
            "who_name": "octenidine, combinations"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02A",
            "level3_description": "UTEROTONICS",
            "level4": "G02AB",
            "level4_description": "Ergot alkaloids",
            "level5": "G02AB01",
            "who_name": "methylergometrine"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02A",
            "level3_description": "UTEROTONICS",
            "level4": "G02AB",
            "level4_description": "Ergot alkaloids",
            "level5": "G02AB02",
            "who_name": "ergot alkaloids"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02A",
            "level3_description": "UTEROTONICS",
            "level4": "G02AB",
            "level4_description": "Ergot alkaloids",
            "level5": "G02AB03",
            "who_name": "ergometrine"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02A",
            "level3_description": "UTEROTONICS",
            "level4": "G02AC",
            "level4_description": "Ergot alkaloids and oxytocin incl. analogues, in combination",
            "level5": "G02AC01",
            "who_name": "methylergometrine and oxytocin"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02A",
            "level3_description": "UTEROTONICS",
            "level4": "G02AD",
            "level4_description": "Prostaglandins",
            "level5": "G02AD01",
            "who_name": "dinoprost"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02A",
            "level3_description": "UTEROTONICS",
            "level4": "G02AD",
            "level4_description": "Prostaglandins",
            "level5": "G02AD02",
            "who_name": "dinoprostone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02A",
            "level3_description": "UTEROTONICS",
            "level4": "G02AD",
            "level4_description": "Prostaglandins",
            "level5": "G02AD03",
            "who_name": "gemeprost"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02A",
            "level3_description": "UTEROTONICS",
            "level4": "G02AD",
            "level4_description": "Prostaglandins",
            "level5": "G02AD04",
            "who_name": "carboprost"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02A",
            "level3_description": "UTEROTONICS",
            "level4": "G02AD",
            "level4_description": "Prostaglandins",
            "level5": "G02AD05",
            "who_name": "sulprostone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02A",
            "level3_description": "UTEROTONICS",
            "level4": "G02AD",
            "level4_description": "Prostaglandins",
            "level5": "G02AD06",
            "who_name": "misoprostol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02B",
            "level3_description": "CONTRACEPTIVES FOR TOPICAL USE",
            "level4": "G02BA",
            "level4_description": "Intrauterine contraceptives",
            "level5": "G02BA01",
            "who_name": "plastic IUD"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02B",
            "level3_description": "CONTRACEPTIVES FOR TOPICAL USE",
            "level4": "G02BA",
            "level4_description": "Intrauterine contraceptives",
            "level5": "G02BA02",
            "who_name": "plastic IUD with copper"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02B",
            "level3_description": "CONTRACEPTIVES FOR TOPICAL USE",
            "level4": "G02BA",
            "level4_description": "Intrauterine contraceptives",
            "level5": "G02BA03",
            "who_name": "plastic IUD with progestogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02B",
            "level3_description": "CONTRACEPTIVES FOR TOPICAL USE",
            "level4": "G02BB",
            "level4_description": "Intravaginal contraceptives",
            "level5": "G02BB01",
            "who_name": "vaginal ring with progestogen and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02B",
            "level3_description": "CONTRACEPTIVES FOR TOPICAL USE",
            "level4": "G02BB",
            "level4_description": "Intravaginal contraceptives",
            "level5": "G02BB02",
            "who_name": "vaginal ring with progestogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02C",
            "level3_description": "OTHER GYNECOLOGICALS",
            "level4": "G02CA",
            "level4_description": "Sympathomimetics, labour repressants",
            "level5": "G02CA01",
            "who_name": "ritodrine"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02C",
            "level3_description": "OTHER GYNECOLOGICALS",
            "level4": "G02CA",
            "level4_description": "Sympathomimetics, labour repressants",
            "level5": "G02CA02",
            "who_name": "buphenine"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02C",
            "level3_description": "OTHER GYNECOLOGICALS",
            "level4": "G02CA",
            "level4_description": "Sympathomimetics, labour repressants",
            "level5": "G02CA03",
            "who_name": "fenoterol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02C",
            "level3_description": "OTHER GYNECOLOGICALS",
            "level4": "G02CB",
            "level4_description": "Prolactine inhibitors",
            "level5": "G02CB01",
            "who_name": "bromocriptine"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02C",
            "level3_description": "OTHER GYNECOLOGICALS",
            "level4": "G02CB",
            "level4_description": "Prolactine inhibitors",
            "level5": "G02CB02",
            "who_name": "lisuride"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02C",
            "level3_description": "OTHER GYNECOLOGICALS",
            "level4": "G02CB",
            "level4_description": "Prolactine inhibitors",
            "level5": "G02CB03",
            "who_name": "cabergoline"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02C",
            "level3_description": "OTHER GYNECOLOGICALS",
            "level4": "G02CB",
            "level4_description": "Prolactine inhibitors",
            "level5": "G02CB04",
            "who_name": "quinagolide"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02C",
            "level3_description": "OTHER GYNECOLOGICALS",
            "level4": "G02CB",
            "level4_description": "Prolactine inhibitors",
            "level5": "G02CB05",
            "who_name": "metergoline"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02C",
            "level3_description": "OTHER GYNECOLOGICALS",
            "level4": "G02CB",
            "level4_description": "Prolactine inhibitors",
            "level5": "G02CB06",
            "who_name": "terguride"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02C",
            "level3_description": "OTHER GYNECOLOGICALS",
            "level4": "G02CC",
            "level4_description": "Antiinflammatory products for vaginal administration",
            "level5": "G02CC01",
            "who_name": "ibuprofen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02C",
            "level3_description": "OTHER GYNECOLOGICALS",
            "level4": "G02CC",
            "level4_description": "Antiinflammatory products for vaginal administration",
            "level5": "G02CC02",
            "who_name": "naproxen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02C",
            "level3_description": "OTHER GYNECOLOGICALS",
            "level4": "G02CC",
            "level4_description": "Antiinflammatory products for vaginal administration",
            "level5": "G02CC03",
            "who_name": "benzydamine"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02C",
            "level3_description": "OTHER GYNECOLOGICALS",
            "level4": "G02CC",
            "level4_description": "Antiinflammatory products for vaginal administration",
            "level5": "G02CC04",
            "who_name": "flunoxaprofen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02C",
            "level3_description": "OTHER GYNECOLOGICALS",
            "level4": "G02CX",
            "level4_description": "Other gynecologicals",
            "level5": "G02CX01",
            "who_name": "atosiban"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02C",
            "level3_description": "OTHER GYNECOLOGICALS",
            "level4": "G02CX",
            "level4_description": "Other gynecologicals",
            "level5": "G02CX02",
            "who_name": "flibanserin"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02C",
            "level3_description": "OTHER GYNECOLOGICALS",
            "level4": "G02CX",
            "level4_description": "Other gynecologicals",
            "level5": "G02CX03",
            "who_name": "Agni casti fructus"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02C",
            "level3_description": "OTHER GYNECOLOGICALS",
            "level4": "G02CX",
            "level4_description": "Other gynecologicals",
            "level5": "G02CX04",
            "who_name": "Cimicifugae rhizoma"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G02",
            "level2_description": "OTHER GYNECOLOGICALS",
            "level3": "G02C",
            "level3_description": "OTHER GYNECOLOGICALS",
            "level4": "G02CX",
            "level4_description": "Other gynecologicals",
            "level5": "G02CX05",
            "who_name": "bremelanotide"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03AA01",
            "who_name": "etynodiol and ethinylestradiol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03AA02",
            "who_name": "quingestanol and ethinylestradiol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03AA03",
            "who_name": "lynestrenol and ethinylestradiol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03AA04",
            "who_name": "megestrol and ethinylestradiol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03AA05",
            "who_name": "norethisterone and ethinylestradiol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03AA06",
            "who_name": "norgestrel and ethinylestradiol"
        }
    ],
    "page_meta": {
        "limit": 1000,
        "next": "/chembl/api/data/atc_class.json?limit=1000&offset=2000",
        "offset": 1000,
        "previous": "/chembl/api/data/atc_class.json?limit=1000&offset=0",
        "total_count": 5265
    }
}
